{"docstore/metadata": {"5ff58a23-ab03-4529-b807-857608ed8624": {"doc_hash": "d10c6b45a0dfb27ef95edf4cd23cd9614ef422c29f6fe6eb50e79bff6ed0b03a"}, "df6320b3-6fc7-4e5a-874f-07a11f71717e": {"doc_hash": "0e08bb4017b77a26ce4f373b377a1e0946dac0dbf3d1705bef04fb517271d691"}, "a9da3a50-4971-44a3-901a-6f212b5f4210": {"doc_hash": "f14886db27d370426b7b1bea94f37440400f5959289d63a58479e43e77526525"}, "d08609ce-3f96-49f5-bf82-9ef617ac3ba2": {"doc_hash": "d1b1b58489d5346c04f7789ef35a8342bf7923a99fefa84d5aa45cbd5e0dff24"}, "37a0c2d9-23a3-4f08-b1e6-29e3d0a271d3": {"doc_hash": "76a3c2fa907997b864457a03b6d19293f75907d8de5645904817946b64a02a48"}, "4402d63c-bb67-4665-a6c7-816a3f10443f": {"doc_hash": "2ca64f244d6f07d27b64bc2dd52072e693d751714b215fd4881b6f1507807a04"}, "f114a944-4639-4483-8c07-58ae0985d68a": {"doc_hash": "b46d2095d74986d642987e3d9b6a62f267c6df312af829e37c800bb7642ab40c"}, "7478fe7e-3fac-43c6-a333-ba873692c862": {"doc_hash": "0719df24b02ce213429aa95ee747b8357fc457916d13a2039a8b4e6fe4014bdd"}, "ea4f9902-39fe-4237-bb1c-9a288b3a7d62": {"doc_hash": "b1f4d710103d927292b9193f69bd0532c0d26a099a278ceb44762edf5fe56a3b"}, "59c6bb13-f171-460e-a1ca-9659b8619e3e": {"doc_hash": "a10b5381543bb4a03146a0843b699689e5791f1566b22fd85b6f8757ed5df432"}, "9b5a05a3-6a2a-4f98-9d16-ff2d8f98b294": {"doc_hash": "a48df3ff7deca7f4c3016ed0b522fa588c7107a6b89f86dfb7e32b46a18c983b"}, "a3ae29db-75c0-4746-a6a7-ca7082669b01": {"doc_hash": "95742f1bfe203c67154af278904dab9b584815141333fcbff2e5d606ca9d97fd"}, "60573379-1a34-4523-ab01-e021c584644e": {"doc_hash": "9bbcc7bc26e230775b1fac88e023c8debe0010dcaff26d5cbd8d95ec9a29d4b2"}, "354c1106-7dbf-4373-be87-68eddaacffb3": {"doc_hash": "29d84caa04647b169ffaa188fe9f2a7f9dc5d4dd18c56a23097b6bb88cddea5a"}, "b96f75af-c04a-45ac-ab4f-9cefa0c0858f": {"doc_hash": "6aac7cb8feaec2eee0b363b315e5f70e7122bcffba847e4e4c56b5a9adc3455d"}, "b4f2d521-a3a4-4e5b-bb4e-c3cf00f268e8": {"doc_hash": "1e3e47ed1467e935a21f4949ddc132420479a6f0f829ade5262bf8c8db87f318"}, "e370fa72-1940-452f-b541-be9a1d27bbff": {"doc_hash": "a97f0bc647a8e4715933d69f272a1a861de041bcb5a5681eead04626d306ebee"}, "05e4217d-ebb8-4b7f-8e53-31519b6d26b2": {"doc_hash": "ec8256382c2ceee5abcbb5f68bb78f8815ba1f86e3bd12deb24977c28b7e059d"}, "aad43c4b-52bd-456f-a94c-8eebab4763c0": {"doc_hash": "d5ae44572d27b25a1516e493ce7ef5ead0116052bf28353e44345ba458bf45c7", "ref_doc_id": "5ff58a23-ab03-4529-b807-857608ed8624"}, "d9920b5d-0fb8-4338-97ab-43f765780e3e": {"doc_hash": "aa4004685ab8588350abba920d31eef930f06e8f541491fcfb202fbf6164db07", "ref_doc_id": "5ff58a23-ab03-4529-b807-857608ed8624"}, "2acc2034-59fb-45bc-a300-5ea3b010882f": {"doc_hash": "36753b5972cc31c1cc2d7d7c384b71b55b979a07d69f7233e93b2497a89a746f", "ref_doc_id": "df6320b3-6fc7-4e5a-874f-07a11f71717e"}, "bcc63ca3-f5af-4464-a786-476b3280e988": {"doc_hash": "bcdccf8376d188901213a632343e771034877d7ca465dcbad3b70b949a318234", "ref_doc_id": "df6320b3-6fc7-4e5a-874f-07a11f71717e"}, "7b8a08a3-a61c-4feb-bf14-0de318eae695": {"doc_hash": "66dbae1a7b878a313c7d38032c91ef329f843545dd1f79d841ba6745df5b4b04", "ref_doc_id": "df6320b3-6fc7-4e5a-874f-07a11f71717e"}, "a69a04e5-8581-4750-be7f-eea56c7f176b": {"doc_hash": "914f469d1101f1b0cb92f5e624ad99a7820a60714e542a0b1fef4aadbcfc0bdf", "ref_doc_id": "a9da3a50-4971-44a3-901a-6f212b5f4210"}, "2f90b85a-8bda-4488-af8c-2d7c23fc9757": {"doc_hash": "5ebd97f40cb918ab22a39445be6df5ef5dd35b45320291884425b5d4ad9b7589", "ref_doc_id": "a9da3a50-4971-44a3-901a-6f212b5f4210"}, "70deb045-6a17-4c22-8e6e-9b9a81e25550": {"doc_hash": "eb09fe58f92d95c6b0c07f559ae9d2a8057acbf03e09eca7a06135ed1314618f", "ref_doc_id": "a9da3a50-4971-44a3-901a-6f212b5f4210"}, "a17a847a-7141-46d1-a3ff-b2d0e454dd5b": {"doc_hash": "6f1dc92684fc72e81a8b1a413713b4adb1e736af222925a794af4de99aa51f53", "ref_doc_id": "d08609ce-3f96-49f5-bf82-9ef617ac3ba2"}, "1b3758a4-3124-44d6-8e40-e721a916db70": {"doc_hash": "8164b85455da73e34f34048579f3fa31ed1785fac38dea29cba61395aa1132aa", "ref_doc_id": "d08609ce-3f96-49f5-bf82-9ef617ac3ba2"}, "b1ed2eda-6e70-484e-8f90-8e607dc0e703": {"doc_hash": "2ec92fe16f20bc0708a62c5803bb84189245e1a6808abf199495d989b0efa824", "ref_doc_id": "d08609ce-3f96-49f5-bf82-9ef617ac3ba2"}, "1f1cd511-86e9-4bee-b8a9-b3911bd7e284": {"doc_hash": "350e4807f8d20e0b13a52a7f23a8e2d1d7efad3f8c9827159deb15dbf8d0b5f1", "ref_doc_id": "37a0c2d9-23a3-4f08-b1e6-29e3d0a271d3"}, "bc8b22a1-202e-482d-a609-4b6e5c1b3cda": {"doc_hash": "a3a6082957905b2fe7f1369e61330abcd9b64c3dbdb77e6d9a23deb0988a001d", "ref_doc_id": "37a0c2d9-23a3-4f08-b1e6-29e3d0a271d3"}, "a835dbdc-ca55-4146-8d33-5c0745b456d4": {"doc_hash": "a88ff5c98f8ae1fab2348bc8971e735a88c944ada540a93a7ba1b04643f47b88", "ref_doc_id": "37a0c2d9-23a3-4f08-b1e6-29e3d0a271d3"}, "f9180fa7-4324-47cd-a349-4ced7a01da30": {"doc_hash": "4dab18a7378e28f87e07e0d288f5ba6506e73d5525e6aa8ae7deb0d02ca5bd2e", "ref_doc_id": "4402d63c-bb67-4665-a6c7-816a3f10443f"}, "8b54ddd7-7637-40d9-a640-25073a8a52df": {"doc_hash": "b3ef28497e34a05629d057c393d9117c4d3d8079bef793c0d3088905346a3506", "ref_doc_id": "4402d63c-bb67-4665-a6c7-816a3f10443f"}, "45d26c4c-7736-4feb-94c2-166a5a91efc9": {"doc_hash": "5cc2a1442c85426de180e0e9a35a401ee2924f774f00fc2884d8c3bd0ec57320", "ref_doc_id": "f114a944-4639-4483-8c07-58ae0985d68a"}, "bd9ee170-52e3-4c2c-9a25-e20908d3ad2b": {"doc_hash": "a1cbc6972ef4a833e9e80075d926c756059b8ddff39253cfda1d37e6a8cae19a", "ref_doc_id": "f114a944-4639-4483-8c07-58ae0985d68a"}, "b5a18796-f055-47b8-ab94-fde9b38dcc4a": {"doc_hash": "b686bb5dbb3b487642e3df1322a6b94787844d113bfaaa29ccd39fcc11e5ff79", "ref_doc_id": "f114a944-4639-4483-8c07-58ae0985d68a"}, "250ad555-4930-43a6-9e26-b66d8986ec27": {"doc_hash": "4c305fb01e1506722cdd038dd127fed40ce47eed1bdf500d35a103a839324559", "ref_doc_id": "7478fe7e-3fac-43c6-a333-ba873692c862"}, "b0e3fd18-bd56-4710-8e07-ec08b585f0f6": {"doc_hash": "651b6578cde1b1993e35ba7873282ba80982e9c96afdd95e025edf3c8f5d6833", "ref_doc_id": "7478fe7e-3fac-43c6-a333-ba873692c862"}, "170eef08-0912-4e13-94f2-cbc9fb8cffc4": {"doc_hash": "1765809ab7abee36f1bace70e8b77ac57703160845664934c116747cd83cf82e", "ref_doc_id": "7478fe7e-3fac-43c6-a333-ba873692c862"}, "03e4c841-5144-435b-8498-aa12933ce1e0": {"doc_hash": "6ea95ad970869234b63bd2a195e123508e83273cb0d5e491b930fc8d0ab30467", "ref_doc_id": "7478fe7e-3fac-43c6-a333-ba873692c862"}, "7919231f-388c-47f1-b1f1-bcfcea7f1c4e": {"doc_hash": "4f1abbd02dd00d631689a1822d8e533a6398b839bac88e077bd015408a20da6c", "ref_doc_id": "ea4f9902-39fe-4237-bb1c-9a288b3a7d62"}, "eb22debd-ff37-4548-abaf-d11a0d90cf56": {"doc_hash": "c5adfed87e4ac2aa5cfdce3e73475239c4fb0964cf6283d54eff5e3777aaca9a", "ref_doc_id": "ea4f9902-39fe-4237-bb1c-9a288b3a7d62"}, "21d031ff-af3d-499e-bbd1-a9df85715683": {"doc_hash": "da3cf16b43f40a12f281fa9a6fe2f36fb6daef0e9cbdad6a994b8c37dcfc7157", "ref_doc_id": "ea4f9902-39fe-4237-bb1c-9a288b3a7d62"}, "35bee021-e562-4031-b71f-04c363aa78dd": {"doc_hash": "7bd4013fe964d45cdf7b4bd8c2b8fcde604b4ecab552f048b12699c9081d820f", "ref_doc_id": "59c6bb13-f171-460e-a1ca-9659b8619e3e"}, "bbf9e1dd-9421-48f9-85b5-5041812e0e79": {"doc_hash": "12cbd2aaf9a2bee7e2c7199ad9ff8f20fbcc6b54bba5114ccf47756dd75c3b16", "ref_doc_id": "59c6bb13-f171-460e-a1ca-9659b8619e3e"}, "42b2f301-3c13-487d-acfc-47c718e50dd0": {"doc_hash": "14e26a8e8d05899bc733c13e1ee01c3dc1284c553477deab7e699bd8c5729bde", "ref_doc_id": "59c6bb13-f171-460e-a1ca-9659b8619e3e"}, "1ab76d8f-58a7-4141-ba7e-931fc48c8a44": {"doc_hash": "83dd72595db2aac1f7b499021d78b31d56187c5b63dad20efca5a22338551f72", "ref_doc_id": "9b5a05a3-6a2a-4f98-9d16-ff2d8f98b294"}, "82a3716d-4285-4456-b7dc-856f97b2e57c": {"doc_hash": "4e5d55e34f2c10609918d190f730536f6cf01aada10f74079e909a217f1f0765", "ref_doc_id": "9b5a05a3-6a2a-4f98-9d16-ff2d8f98b294"}, "6d5ca368-bf0a-4999-8105-a2cf33baf7c3": {"doc_hash": "ec90213bb7814c6b4484b45aa8b69fd62a83f5da5d3d017f88020c2205cc45fe", "ref_doc_id": "9b5a05a3-6a2a-4f98-9d16-ff2d8f98b294"}, "bd1f66a1-be73-4092-9c49-218bf182b7e2": {"doc_hash": "8d2f5a4d87b37788ea05ef6476aa0f75c552e081b2187d8d82985ee28c39e549", "ref_doc_id": "9b5a05a3-6a2a-4f98-9d16-ff2d8f98b294"}, "29093c73-7f46-49cf-bbb2-ae3a45493067": {"doc_hash": "e06f0542484f79549a9d01cc4413643a39a7a2871e32904b1b0ab542ead0f29d", "ref_doc_id": "a3ae29db-75c0-4746-a6a7-ca7082669b01"}, "cd6991e9-3d22-4b82-a0c8-b02abff188ee": {"doc_hash": "884e1c52749d6aca085dcf4e41d690f3a21143f5965de2287e8a821a6c7872ab", "ref_doc_id": "a3ae29db-75c0-4746-a6a7-ca7082669b01"}, "ec558eee-5f8a-4269-a304-2b93d23268ce": {"doc_hash": "59637754e3852671016fb5e075c9f785b5127f39cabd2d3142dcbb52f814838b", "ref_doc_id": "a3ae29db-75c0-4746-a6a7-ca7082669b01"}, "7d9d58b5-da10-4121-966e-20f202083e24": {"doc_hash": "e45c5168b7018313d3bf6238bf7317d6f0a99fb59962f88e1a0f65bf63e371bb", "ref_doc_id": "60573379-1a34-4523-ab01-e021c584644e"}, "47dfda85-518f-428f-9e85-da0d636d3111": {"doc_hash": "a93dda53d6771783e2568838c087670c2b3dde70029f234f6860b0fb4ebbb14c", "ref_doc_id": "60573379-1a34-4523-ab01-e021c584644e"}, "30c08b43-7bac-43c6-b771-3f6df187b7a9": {"doc_hash": "e0153f67a87fb7f5ea01557e79e1a056ea5f36f9bcada2cd83e2b98c4b19f409", "ref_doc_id": "354c1106-7dbf-4373-be87-68eddaacffb3"}, "deca32bb-429b-43b2-9276-0511e9c52539": {"doc_hash": "c3a9d30c047f10a7e4a551314f2230108cfc4d7aee6ff45e6a8d8d2134756c50", "ref_doc_id": "354c1106-7dbf-4373-be87-68eddaacffb3"}, "e312f406-4c13-4881-a21f-da9ae85969cf": {"doc_hash": "04eb68f12aefd808a2f810143cb214c2e20fae36f8387374858735c36330a7ac", "ref_doc_id": "b96f75af-c04a-45ac-ab4f-9cefa0c0858f"}, "81e87b34-7d24-4ac7-9176-bcd47aef2c6d": {"doc_hash": "8c2b443cf08c34a5998b593f0410b5a0171347f048b446e2e932a3cbcef9e4d0", "ref_doc_id": "b96f75af-c04a-45ac-ab4f-9cefa0c0858f"}, "3136e20c-72c4-4e3a-a25f-1e01bfbd7258": {"doc_hash": "8d4483ed82e0e60e48362fc37b00d1f75842d5d579a1f67049024332ae303d12", "ref_doc_id": "b96f75af-c04a-45ac-ab4f-9cefa0c0858f"}, "4320e6dd-9139-4331-b0cc-f1828897074f": {"doc_hash": "19c16ddde20f11c7fd6d05af1e7425c292a4ee44f1e819999e99e6c70b3d4992", "ref_doc_id": "b4f2d521-a3a4-4e5b-bb4e-c3cf00f268e8"}, "f36052f6-5b03-4731-9e8a-d1a2e4dccf93": {"doc_hash": "3f627f15e99af00997aff2ef80d1d5f596355a0eac4a7bbaac0063d0704c6ef4", "ref_doc_id": "b4f2d521-a3a4-4e5b-bb4e-c3cf00f268e8"}, "dd5efec8-e471-400b-af2b-e3f016f5f02b": {"doc_hash": "228bb1e6458038875d0a6eeab90713049840b2da6d783056825f618e1c918cae", "ref_doc_id": "b4f2d521-a3a4-4e5b-bb4e-c3cf00f268e8"}, "6dcb3980-07d8-480d-bdd4-4ba736e63eac": {"doc_hash": "5109ff826cd07ffd617852ec4ef0cf3909cc9144ac4ff037e0c6a53fa35be2d8", "ref_doc_id": "e370fa72-1940-452f-b541-be9a1d27bbff"}, "7e2283e8-1552-47ec-aedb-d926e1b5c24b": {"doc_hash": "d1db6eb81ffe40e398358ff40fef9929cc4fca4a36abcf16cbf615bee8808b3b", "ref_doc_id": "e370fa72-1940-452f-b541-be9a1d27bbff"}, "e1e36274-be71-4771-a500-5becb9943cae": {"doc_hash": "5e36ef0565c7b437dbcaec5c5330a282bff7bae045ef9ad423558504fa1afa7d", "ref_doc_id": "e370fa72-1940-452f-b541-be9a1d27bbff"}, "af84de6f-6f8b-44a7-9780-4e917c157c25": {"doc_hash": "e8dc5a1f72a90641d855bafe2f6c968ceea21b05e3039cc62db324810a40c565", "ref_doc_id": "05e4217d-ebb8-4b7f-8e53-31519b6d26b2"}, "ea059d17-73b0-419d-abbb-121836be50cb": {"doc_hash": "1b689815e8738aebb31f1b555d0d0959060c66c8ad84eba5c2e8bd19b8368af3", "ref_doc_id": "05e4217d-ebb8-4b7f-8e53-31519b6d26b2"}, "1a61ebca-408f-485d-8666-d7a2c1f85455": {"doc_hash": "4a1f2f8ea3ab87d7c5fe44190401057f4e387b19813564136a9067b5f097bebf", "ref_doc_id": "05e4217d-ebb8-4b7f-8e53-31519b6d26b2"}}, "docstore/ref_doc_info": {"5ff58a23-ab03-4529-b807-857608ed8624": {"node_ids": ["aad43c4b-52bd-456f-a94c-8eebab4763c0", "d9920b5d-0fb8-4338-97ab-43f765780e3e"], "metadata": {"page_label": "381", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}}, "df6320b3-6fc7-4e5a-874f-07a11f71717e": {"node_ids": ["2acc2034-59fb-45bc-a300-5ea3b010882f", "bcc63ca3-f5af-4464-a786-476b3280e988", "7b8a08a3-a61c-4feb-bf14-0de318eae695"], "metadata": {"page_label": "382", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}}, "a9da3a50-4971-44a3-901a-6f212b5f4210": {"node_ids": ["a69a04e5-8581-4750-be7f-eea56c7f176b", "2f90b85a-8bda-4488-af8c-2d7c23fc9757", "70deb045-6a17-4c22-8e6e-9b9a81e25550"], "metadata": {"page_label": "383", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}}, "d08609ce-3f96-49f5-bf82-9ef617ac3ba2": {"node_ids": ["a17a847a-7141-46d1-a3ff-b2d0e454dd5b", "1b3758a4-3124-44d6-8e40-e721a916db70", "b1ed2eda-6e70-484e-8f90-8e607dc0e703"], "metadata": {"page_label": "384", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}}, "37a0c2d9-23a3-4f08-b1e6-29e3d0a271d3": {"node_ids": ["1f1cd511-86e9-4bee-b8a9-b3911bd7e284", "bc8b22a1-202e-482d-a609-4b6e5c1b3cda", "a835dbdc-ca55-4146-8d33-5c0745b456d4"], "metadata": {"page_label": "385", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}}, "4402d63c-bb67-4665-a6c7-816a3f10443f": {"node_ids": ["f9180fa7-4324-47cd-a349-4ced7a01da30", "8b54ddd7-7637-40d9-a640-25073a8a52df"], "metadata": {"page_label": "386", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}}, "f114a944-4639-4483-8c07-58ae0985d68a": {"node_ids": ["45d26c4c-7736-4feb-94c2-166a5a91efc9", "bd9ee170-52e3-4c2c-9a25-e20908d3ad2b", "b5a18796-f055-47b8-ab94-fde9b38dcc4a"], "metadata": {"page_label": "387", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}}, "7478fe7e-3fac-43c6-a333-ba873692c862": {"node_ids": ["250ad555-4930-43a6-9e26-b66d8986ec27", "b0e3fd18-bd56-4710-8e07-ec08b585f0f6", "170eef08-0912-4e13-94f2-cbc9fb8cffc4", "03e4c841-5144-435b-8498-aa12933ce1e0"], "metadata": {"page_label": "388", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}}, "ea4f9902-39fe-4237-bb1c-9a288b3a7d62": {"node_ids": ["7919231f-388c-47f1-b1f1-bcfcea7f1c4e", "eb22debd-ff37-4548-abaf-d11a0d90cf56", "21d031ff-af3d-499e-bbd1-a9df85715683"], "metadata": {"page_label": "389", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}}, "59c6bb13-f171-460e-a1ca-9659b8619e3e": {"node_ids": ["35bee021-e562-4031-b71f-04c363aa78dd", "bbf9e1dd-9421-48f9-85b5-5041812e0e79", "42b2f301-3c13-487d-acfc-47c718e50dd0"], "metadata": {"page_label": "390", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}}, "9b5a05a3-6a2a-4f98-9d16-ff2d8f98b294": {"node_ids": ["1ab76d8f-58a7-4141-ba7e-931fc48c8a44", "82a3716d-4285-4456-b7dc-856f97b2e57c", "6d5ca368-bf0a-4999-8105-a2cf33baf7c3", "bd1f66a1-be73-4092-9c49-218bf182b7e2"], "metadata": {"page_label": "391", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}}, "a3ae29db-75c0-4746-a6a7-ca7082669b01": {"node_ids": ["29093c73-7f46-49cf-bbb2-ae3a45493067", "cd6991e9-3d22-4b82-a0c8-b02abff188ee", "ec558eee-5f8a-4269-a304-2b93d23268ce"], "metadata": {"page_label": "392", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}}, "60573379-1a34-4523-ab01-e021c584644e": {"node_ids": ["7d9d58b5-da10-4121-966e-20f202083e24", "47dfda85-518f-428f-9e85-da0d636d3111"], "metadata": {"page_label": "393", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}}, "354c1106-7dbf-4373-be87-68eddaacffb3": {"node_ids": ["30c08b43-7bac-43c6-b771-3f6df187b7a9", "deca32bb-429b-43b2-9276-0511e9c52539"], "metadata": {"page_label": "394", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}}, "b96f75af-c04a-45ac-ab4f-9cefa0c0858f": {"node_ids": ["e312f406-4c13-4881-a21f-da9ae85969cf", "81e87b34-7d24-4ac7-9176-bcd47aef2c6d", "3136e20c-72c4-4e3a-a25f-1e01bfbd7258"], "metadata": {"page_label": "395", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}}, "b4f2d521-a3a4-4e5b-bb4e-c3cf00f268e8": {"node_ids": ["4320e6dd-9139-4331-b0cc-f1828897074f", "f36052f6-5b03-4731-9e8a-d1a2e4dccf93", "dd5efec8-e471-400b-af2b-e3f016f5f02b"], "metadata": {"page_label": "396", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}}, "e370fa72-1940-452f-b541-be9a1d27bbff": {"node_ids": ["6dcb3980-07d8-480d-bdd4-4ba736e63eac", "7e2283e8-1552-47ec-aedb-d926e1b5c24b", "e1e36274-be71-4771-a500-5becb9943cae"], "metadata": {"page_label": "397", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}}, "05e4217d-ebb8-4b7f-8e53-31519b6d26b2": {"node_ids": ["af84de6f-6f8b-44a7-9780-4e917c157c25", "ea059d17-73b0-419d-abbb-121836be50cb", "1a61ebca-408f-485d-8666-d7a2c1f85455"], "metadata": {"page_label": "398", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}}}, "docstore/data": {"aad43c4b-52bd-456f-a94c-8eebab4763c0": {"__data__": {"id_": "aad43c4b-52bd-456f-a94c-8eebab4763c0", "embedding": null, "metadata": {"page_label": "381", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5ff58a23-ab03-4529-b807-857608ed8624", "node_type": "4", "metadata": {"page_label": "381", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "d10c6b45a0dfb27ef95edf4cd23cd9614ef422c29f6fe6eb50e79bff6ed0b03a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d9920b5d-0fb8-4338-97ab-43f765780e3e", "node_type": "1", "metadata": {}, "hash": "fc6fc0c716dd0b7256b592dc7f259411c5f486473e60c29245a65f246e4a97ac", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "N\u00b0 22 | 8 novembre 2022\nBEH 22 | 8 novembre 2022 | 381\nLa reproduction (totale ou partielle) du BEH est soumise \u00e0 l'accord pr\u00e9alable de Sant\u00e9 publique France.\nConform\u00e9ment \u00e0 l'article L. 122-5 du code de la propri\u00e9t\u00e9 intellectuelle, les courtes citations ne sont pas\nsoumises \u00e0 autorisation pr\u00e9alable, sous r\u00e9serve que soient indiqu\u00e9s clairement le nom de l'auteur et la\nsource, et qu'elles ne portent pas atteinte \u00e0 l'int\u00e9grit\u00e9 et \u00e0 l'esprit de l'\u0153uvre. Les atteintes au droit d'auteur\nattach\u00e9 au BEH sont passibles d'un contentieux devant la juridiction comp\u00e9tente.\nDirecteur de la publication : La\u00ebtitia Huiart, directrice scientifique, adjointe \u00e0 la directrice g\u00e9n\u00e9rale de\nSant\u00e9 publique France\nR\u00e9dactrice en chef : Val\u00e9rie Colombani-Cocuron, Sant\u00e9 publique France,\nR\u00e9dactrice en chef adjointe : Fr\u00e9d\u00e9rique Biton-Debernardi\nResponsable du contenu en anglais : Chlo\u00eb Chester\nSecr\u00e9tariat de r\u00e9daction : Val\u00e9rie Contactsis\nComit\u00e9 de r\u00e9daction : Rapha\u00ebl Andler, Sant\u00e9 publique France ; Thierry Blanchon, Iplesp ; Florence BodeauLivinec, EHESP ; Julie Boudet-Berquier, Sant\u00e9 publique France ; Kathleen Chami, Sant\u00e9 publique France ;\nBertrand Gagni\u00e8re, Sant\u00e9 publique France - Bretagne ; Isabelle Gr\u00e9my, ORS \u00cele-de-France ; Anne Guinard /\nDamien Mouly, Sant\u00e9 publique France - Occitanie ; Nathalie Jourdan-Da Silva, Sant\u00e9 publique France ;\nPhilippe Magne, Centre national de gestion des praticiens hospitaliers et des personnels de direction de\nla fonction publique hospitali\u00e8re ; Val\u00e9rie Oli\u00e9, Sant\u00e9 publique France ; Alexia Peyronnet, Sant\u00e9 publique\nFrance ; H\u00e9l\u00e8ne Therre, Sant\u00e9 publique France ; Sophie Vaux, Sant\u00e9 publique France ; Isabelle Villena,\nCHU Reims.\nSant\u00e9 publique France - Site Internet :\nPr\u00e9presse : Luminess\nISSN : 1953-8030\nRetrouvez ce num\u00e9ro ainsi que les archives du Bulletin \u00e9pid\u00e9miologique hebdomadaire sur\n\n// World diabetes day, November 14, 2022\nCoordination scientifique // Scientific coordination\nSandrine Fosse-Edorh\nEt pour le Comit\u00e9 de r\u00e9daction du BEH : Bertrand Gagni\u00e8re (Sant\u00e9 publique France - Bretagne), Val\u00e9rie Oli\u00e9 (Sant\u00e9 publique France)\nSOMMAIRE // Contents\n>\n\u00c9DITORIAL // Editorial\nEntred 3 est arriv\u00e9 !\n// Entred 3 has arrived!...............................................", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2216, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d9920b5d-0fb8-4338-97ab-43f765780e3e": {"__data__": {"id_": "d9920b5d-0fb8-4338-97ab-43f765780e3e", "embedding": null, "metadata": {"page_label": "381", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5ff58a23-ab03-4529-b807-857608ed8624", "node_type": "4", "metadata": {"page_label": "381", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "d10c6b45a0dfb27ef95edf4cd23cd9614ef422c29f6fe6eb50e79bff6ed0b03a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "aad43c4b-52bd-456f-a94c-8eebab4763c0", "node_type": "1", "metadata": {"page_label": "381", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "d5ae44572d27b25a1516e493ce7ef5ead0116052bf28353e44345ba458bf45c7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "// Entred 3 has arrived!...............................................\nAndr\u00e9 Grimaldi\nProfesseur \u00e9m\u00e9rite, Centre hospitalier universitaire\nPiti\u00e9-Salp\u00eatri\u00e8re, Paris\nARTICLE // Article\n\u00c9tudes Entred : un dispositif\npour am\u00e9liorer la connaissance de l'\u00e9tat\nde sant\u00e9 des personnes pr\u00e9sentant\nun diab\u00e8te en France - Premiers r\u00e9sultats\nde la troisi\u00e8me \u00e9dition conduite en m\u00e9tropole\nen 2019\n// ENTRED studies: Improving knowledge\non the health status of people with diabetes\nin France - First results of the third edition\nconducted in metropolitan France, 2019 ..................\nSandrine Fosse-Edorh et coll.\nSant\u00e9 publique France, Saint-Maurice\nARTICLE // Article\nTabagisme et diab\u00e8te : le temps de l'action\n// Smoking and diabetes: Time for action .................\nVincent Durlach et coll.\nUniversit\u00e9 Reims Champagne-Ardenne, UMR CNRS 7369\nMEDyC, P\u00f4le Cardio-Thoracique, Centre hospitalier\nuniversitaire de Reims", "mimetype": "text/plain", "start_char_idx": 2145, "end_char_idx": 3055, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2acc2034-59fb-45bc-a300-5ea3b010882f": {"__data__": {"id_": "2acc2034-59fb-45bc-a300-5ea3b010882f", "embedding": null, "metadata": {"page_label": "382", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "df6320b3-6fc7-4e5a-874f-07a11f71717e", "node_type": "4", "metadata": {"page_label": "382", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "0e08bb4017b77a26ce4f373b377a1e0946dac0dbf3d1705bef04fb517271d691", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bcc63ca3-f5af-4464-a786-476b3280e988", "node_type": "1", "metadata": {}, "hash": "78c48ef57be890be767e9f7828a6d821a7b535a279a048cdfbf59e0d28df5795", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "382 | 8 novembre 2022 | BEH 22 Journ\u00e9e mondiale du diab\u00e8te, 14 novembre 2022\n\u00c9DITORIAL // Editorial\nENTRED 3 EST ARRIV\u00c9 !\n// ENTRED 3 HAS ARRIVED!\nAndr\u00e9 Grimaldi\nProfesseur \u00e9m\u00e9rite, Centre hospitalier universitaire Piti\u00e9-Salp\u00eatri\u00e8re, Paris\nCe num\u00e9ro th\u00e9matique du Bulletin \u00e9pid\u00e9miolo -\ngique hebdomadaire (BEH), dont la parution co\u00efn -\ncide avec la Journ\u00e9e mondiale du diab\u00e8te, livre les\ntous premiers r\u00e9sultats de la troisi\u00e8me \u00e9dition 2019\nde l'\u00e9tude \u00c9chantillon national t\u00e9moin repr\u00e9sentatif\ndes personnes diab\u00e9tiques (Entred), portant sur un\npeu moins de 10 000 adultes tir\u00e9s au sort.\nCette nouvelle version, tout en suivant une m\u00e9tho -\ndologie similaire \u00e0 celle d'Ent red 1 (2001-2003) et\nd'Entred 2 (2007-2010), a pu b\u00e9n\u00e9ficier des donn\u00e9es\ndu Syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS)\nsur les hospitalisations, durant les 10 ann\u00e9es\npr\u00e9c\u00e9dentes. De plus, un sur- \u00e9chantillonnage\ndes personnes diab\u00e9tiques de type 1 a permis\nd'apporter des donn\u00e9es plus pr\u00e9cises sur cette\npopulation que celles fournies par les \u00e9ditions ant\u00e9 -\nrieures. Le premier article (1) de ce num\u00e9ro rapporte\nles caract\u00e9ristiques recueillies par une enqu\u00eate\naupr\u00e8s des personnes diab\u00e9tiques vivant en France\nm\u00e9tropolitaine, associ\u00e9es aux donn\u00e9es extraites du\nSNDS (des publications ult\u00e9rieures porteront sur\nles populations de La R\u00e9union, de la Guyane et des\nAntilles).\nLe premier int\u00e9r\u00eat de cette publication est de\npermettre la comparaison avec les donn\u00e9es des\n\u00e9ditions ant\u00e9rieures. En ce qui conc erne le diab\u00e8te\nde type 2, si on n'observe pas de progr\u00e8s en termes\nde poids (avec 80% de surpoids et d'ob\u00e9 sit\u00e9) et de\ntabagisme (13%), les publications ult\u00e9rieures diront si\nla diminution rapport\u00e9e de la perte de vue d'un \u0153il\net d'un mal perforant plantaire est corr\u00e9l\u00e9e, comm e\non peut le penser, \u00e0 une am\u00e9lioration de l'\u00e9quilibre\nglyc\u00e9mique. Elles devront aussi confi rmer la diminu -\ntion des comp lications coronariennes, rapport\u00e9es\npar les patients, que pourrait expliquer une plus\nlarge prescription de statines.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1998, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bcc63ca3-f5af-4464-a786-476b3280e988": {"__data__": {"id_": "bcc63ca3-f5af-4464-a786-476b3280e988", "embedding": null, "metadata": {"page_label": "382", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "df6320b3-6fc7-4e5a-874f-07a11f71717e", "node_type": "4", "metadata": {"page_label": "382", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "0e08bb4017b77a26ce4f373b377a1e0946dac0dbf3d1705bef04fb517271d691", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2acc2034-59fb-45bc-a300-5ea3b010882f", "node_type": "1", "metadata": {"page_label": "382", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "36753b5972cc31c1cc2d7d7c384b71b55b979a07d69f7233e93b2497a89a746f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7b8a08a3-a61c-4feb-bf14-0de318eae695", "node_type": "1", "metadata": {}, "hash": "8f0dd0c0b73bb948fa7e9ff13fb1c13ea6f7b51f686a7f84fc93a9f9d51d6365", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Elles devront aussi confi rmer la diminu -\ntion des comp lications coronariennes, rapport\u00e9es\npar les patients, que pourrait expliquer une plus\nlarge prescription de statines. Quoi qu'il en soit, le\nvieillissement enregistr\u00e9 de la population des diab\u00e9 -\ntiques de type 2 et l'allongement de la dur\u00e9e moyenne\ndu diab\u00e8te t\u00e9moignent \u00e0 la fois du ralentissement\nde la progression de l'incidence de la maladie, et de\nl'accroissement de l'esp \u00e9rance de vie des patients\ntrait\u00e9s. Les progr\u00e8s th\u00e9rapeutiques rapport\u00e9s sont\ncertes num\u00e9riquement modestes, mais ils sont\nencourageants et engagent \u00e0 poursuivre les actions\nd'information et de formation des professionnels et\ndes patients. La grande question reste cependant\n(1) Voir \u00ab \u00c9tudes Entred : un dispositif pour am\u00e9liorer la connaissance\nde l'\u00e9tat de sant\u00e9 des personnes pr\u00e9sentant un diab\u00e8te en France -\nPremiers r\u00e9sultats de la troisi\u00e8me \u00e9dition conduite en m\u00e9tropole en 2019 \u00bb\nde Sandrine Fosse-Edorh et coll. dans ce num\u00e9ro.\ncelle de la pr\u00e9vention primaire du diab\u00e8te de type 2,\ngr\u00e2ce \u00e0 l'\u00e9quilibre alimentaire et \u00e0 l'accroissement de\nl'activit\u00e9 physique.\nLes patients diab\u00e9tiques de type 1, comm e on\npouvait s'y attendre sont plus jeunes que les diab\u00e9 -\ntiques de type 2, avec un niveau socio- culturel plus\n\u00e9lev\u00e9. Ils ont un diab\u00e8te plus ancien, pr\u00e9sentent\nmoins de comp lications macrovasculaires, mais\nnettement plus de complications microvasculaires\n(\u0153il, pied, rein, la classique \u00ab triopathie \u00bb diab\u00e9tique).\nCe qui frappe conc ernant ce diab\u00e8te qu'on appelait\njadis \u00ab maigre \u00bb est, en revanche, le pourcentage de\npatients en surpoids ou ob\u00e8ses (50%) et tabagiques\n(25%). Si bien que le ph\u00e9notype moderne du diab\u00e8te\nde type 1 associe \u00e0 la carence insulinique absolue qui\nle caract\u00e9rise le d\u00e9veloppement d'une insulinor\u00e9sis -\ntance, autrefois apanage du diab\u00e8te de type 2.\nD'apr\u00e8s ces premi\u00e8res donn\u00e9es d\u00e9claratives\nd'Entred 3, le tabagisme semble se maintenir \u00e0 un\ntaux \u00e9lev\u00e9 chez les patients diab\u00e9tiques, alors qu'il\ntend \u00e0 r\u00e9gresser dans la population g\u00e9n\u00e9rale. Il fait\nl'objet du deuxi\u00e8me article de ce num\u00e9ro (2).", "mimetype": "text/plain", "start_char_idx": 1824, "end_char_idx": 3897, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7b8a08a3-a61c-4feb-bf14-0de318eae695": {"__data__": {"id_": "7b8a08a3-a61c-4feb-bf14-0de318eae695", "embedding": null, "metadata": {"page_label": "382", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "df6320b3-6fc7-4e5a-874f-07a11f71717e", "node_type": "4", "metadata": {"page_label": "382", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "0e08bb4017b77a26ce4f373b377a1e0946dac0dbf3d1705bef04fb517271d691", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bcc63ca3-f5af-4464-a786-476b3280e988", "node_type": "1", "metadata": {"page_label": "382", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "bcdccf8376d188901213a632343e771034877d7ca465dcbad3b70b949a318234", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "D'apr\u00e8s ces premi\u00e8res donn\u00e9es d\u00e9claratives\nd'Entred 3, le tabagisme semble se maintenir \u00e0 un\ntaux \u00e9lev\u00e9 chez les patients diab\u00e9tiques, alors qu'il\ntend \u00e0 r\u00e9gresser dans la population g\u00e9n\u00e9rale. Il fait\nl'objet du deuxi\u00e8me article de ce num\u00e9ro (2). Le tabac\njoue un r\u00f4le particuli\u00e8rement pervers, puisqu'il est\nun facteur de risque du diab\u00e8te de type 2, \u00e0 la fois\nen favorisant la r\u00e9partition abdominale visc\u00e9rale\ndes graisses, et en induisant fr\u00e9quemment lors de\nl'arr\u00eat de l'int oxication une prise de poids impor -\ntante. En plus de ses propres comp lications, notamment oncologiques et vasculaires, le tabagisme\naggrave les comp lications du diab\u00e8te et singuli\u00e8re -\nment la n\u00e9phropathie diab\u00e9tique. Si on ajoute \u00e0 ces\ndonn\u00e9es \u00e9pid\u00e9miologiques l'exi stence d'un gradient\nsocial concernant l'ob\u00e9sit\u00e9, le diab\u00e8te de type 2,\nle tabagisme, on con\u00e7oit qu'on puisse parler de\n\u00ab synd\u00e9mie \u00bb (intrication de maladies touchant de tr\u00e8s\nlarges populations et s'agg ravant r\u00e9ciproquement).\nL 'origine commune de cette synd\u00e9mie tiendrait au\nd\u00e9veloppement des comp ortements addictifs dans\nune soci\u00e9t\u00e9 de cons ommation, urbanis\u00e9e, s\u00e9denta -\nris\u00e9e, archipellis\u00e9e o\u00f9 chacun, pour lutter cont re la\nmaladie du si\u00e8cle, l'anx iod\u00e9pression, tente d'act iver\nles circuits bio-neuronaux du plaisir, sachant que\ncette derni\u00e8re est deux fois plus fr\u00e9quente chez\nles patients atteints de maladies chroniques. Mais,\nles comportements compulsifs ou la cons ommation\nde drogues qui soulagent le mal-\u00eatre dans l'ins tant,\nl'aggravent secondairement, tandis que le marke -\nting des industriels conc ern\u00e9s stimule le sentiment\n(2) Voir \u00ab Tabagisme et diab\u00e8te : le temps de l'action \u00bb de Vincent Durlach\net coll. dans ce num\u00e9ro.\n>\nAndr\u00e9 Grimaldi\nProfesseur \u00e9m\u00e9rite, Centre hospitalier universitaire Piti\u00e9-Salp\u00eatri\u00e8re, Paris.", "mimetype": "text/plain", "start_char_idx": 3651, "end_char_idx": 5443, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a69a04e5-8581-4750-be7f-eea56c7f176b": {"__data__": {"id_": "a69a04e5-8581-4750-be7f-eea56c7f176b", "embedding": null, "metadata": {"page_label": "383", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a9da3a50-4971-44a3-901a-6f212b5f4210", "node_type": "4", "metadata": {"page_label": "383", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "f14886db27d370426b7b1bea94f37440400f5959289d63a58479e43e77526525", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2f90b85a-8bda-4488-af8c-2d7c23fc9757", "node_type": "1", "metadata": {}, "hash": "503fdf368adc2915c5eda69400157799da17ef5588a551a849dc6df62f2f4143", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Journ\u00e9e mondiale du diab\u00e8te, 14 novembre 2022 BEH 22 | 8 novembre 2022 | 383\nARTICLE // Article\n\u00c9TUDES ENTRED : UN DISPOSITIF POUR AM\u00c9LIORER LA CONNAISSANCE DE L'\u00c9TAT\nDE SANT\u00c9 DES PERSONNES PR\u00c9SENTANT UN DIAB\u00c8TE EN FRANCE - PREMIERS R\u00c9SULTATS\nDE LA TROISI\u00c8ME \u00c9DITION CONDUITE EN M\u00c9TROPOLE EN 2019\n// ENTRED STUDIES: IMPROVING KNOWLEDGE ON THE HEALTH STATUS OF PEOPLE WITH DIABETES IN FRANCE -\nFIRST RESULTS OF THE THIRD EDITION CONDUCTED IN METROPOLITAN FRANCE, 2019\nSandrine Fosse-Edorh 1 (), Clara Piffaretti 1, Leila Saboni 1,\nLaurence Mandereau-Bruno 1, Laetitia B\u00e9n\u00e9zet 1, V\u00e9ronique Raimond 2, Jean-Michel Race 3, Antoine Rachas 4\n1 Sant\u00e9 publique France, Saint-Maurice\n2 Haute Autorit\u00e9 de sant\u00e9, Saint-Denis\n3 Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9, Saint-Denis\n4 Caisse nationale de l'assurance maladie, Paris\nSoumis le 01.08.2022 // Date of submission: 08.01.2022\nR\u00e9sum\u00e9 // Abstract\nIntroduction - La troisi\u00e8me \u00e9dition de l'\u00e9tude \u00ab Echantillon national t\u00e9moin repr\u00e9sentatif des personnes diab\u00e9 -\ntiques \u00bb (Entred 3), men\u00e9e en 2019, a pour objectif de d\u00e9crire les caract\u00e9ristiques des personnes pr\u00e9sentant\nun diab\u00e8te de type 2 (DT2) ou de type 1 (DT1) et leur \u00e9tat de sant\u00e9. Cet article pr\u00e9sente les premiers r\u00e9sultats\nauto-d\u00e9clar\u00e9s par les personnes r\u00e9sidant en France m\u00e9tropolitaine.\nM\u00e9thodes - Un \u00e9chantillon de 9 072 personnes (\u2265 18 ans), trait\u00e9es pharmacologiquement pour un diab\u00e8te a\n\u00e9t\u00e9 tir\u00e9 au sort dans les bases de l 'Assurance maladie (r\u00e9gime g\u00e9n\u00e9ral et s\u00e9curit\u00e9 sociale des ind\u00e9pendants).\nCes personnes ont \u00e9t\u00e9 invit\u00e9es \u00e0 r\u00e9pondre \u00e0 un auto-questionnaire. Les donn\u00e9es du Syst\u00e8me national de\ndonn\u00e9es de sant\u00e9 ont \u00e9t\u00e9 extraites pour l 'ensemble de l'\u00e9chantillon. Des estimations pond\u00e9r\u00e9es ont \u00e9t\u00e9 calcu -\nl\u00e9es tenant compte du plan de sondage et du biais de non-participation par questionnaire.\nR\u00e9sultats - La population d '\u00e9tude incluait 8 728 personnes dont 3 166 (36,3%) ont r\u00e9pondu \u00e0 un question -\nnaire. Parmi elles, 2 714 \u00e9taient identifi\u00e9es comme ayant un DT2, d'\u00e2ge moyen 67,6 ans (+2 ans par rapport\n\u00e0 2007), 55,3% \u00e9taient des hommes (stable/2007), avec une anciennet\u00e9 m\u00e9diane du diab\u00e8te de 10,7 ans.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2155, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2f90b85a-8bda-4488-af8c-2d7c23fc9757": {"__data__": {"id_": "2f90b85a-8bda-4488-af8c-2d7c23fc9757", "embedding": null, "metadata": {"page_label": "383", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a9da3a50-4971-44a3-901a-6f212b5f4210", "node_type": "4", "metadata": {"page_label": "383", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "f14886db27d370426b7b1bea94f37440400f5959289d63a58479e43e77526525", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a69a04e5-8581-4750-be7f-eea56c7f176b", "node_type": "1", "metadata": {"page_label": "383", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "914f469d1101f1b0cb92f5e624ad99a7820a60714e542a0b1fef4aadbcfc0bdf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "70deb045-6a17-4c22-8e6e-9b9a81e25550", "node_type": "1", "metadata": {}, "hash": "069720f0ddea954713423f4d07c45a5717fa9b2ee942eabc192758615fd9f5b1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Parmi elles, 2 714 \u00e9taient identifi\u00e9es comme ayant un DT2, d'\u00e2ge moyen 67,6 ans (+2 ans par rapport\n\u00e0 2007), 55,3% \u00e9taient des hommes (stable/2007), avec une anciennet\u00e9 m\u00e9diane du diab\u00e8te de 10,7 ans.\nEt 412 personnes \u00e9taient identifi\u00e9es comme ayant un DT1, d'\u00e2ge moyen 47 ans, 57% \u00e9taient des hommes\net 55,6% avaient une anciennet\u00e9 du diab\u00e8te \u226520 ans. Le niveau socio-\u00e9conomique des personnes DT1 \u00e9tait\nplus favorable que celui des personnes DT2. Les facteurs de risque de complications \u00e9taient fr\u00e9quents chez\nles personnes DT2, (surpoids/ob\u00e9sit\u00e9 (80,1%), hypertension trait\u00e9e (77,6%), dyslipid\u00e9mie trait\u00e9e (63,8%),\ntabagisme (13,4%), consommation d'alcool \u00e9lev\u00e9e ou s\u00e9v\u00e8re (7%)). Ces facteurs de risque \u00e9taient \u00e9galement\nfr\u00e9quents chez les personnes DT1, notamment le surpoids/ob\u00e9sit\u00e9 (49,9%), la consommation d'alcool (11,3%)\net de tabac (25,3%). Les complications macrovasculaires \u00e9taient plus fr\u00e9quemment autod\u00e9clar\u00e9es chez les\n>\nSandrine Fosse-Edorh\nSant\u00e9 publique France, Saint-Maurice\nillusoire de libert\u00e9 pour mieux assujettir leurs clients.\nLa lutte cont re cette synd\u00e9mie passe donc par une\npolitique de sant\u00e9 publique globale, dont chaque\n\u00e9l\u00e9ment doit \u00eatre \u00e9valu\u00e9. Cette \u00e9valuation r\u00e9guli\u00e8 -\nrement r\u00e9p\u00e9t\u00e9e est indispensable pour d\u00e9cider des\nactions \u00e0 poursuivre ou \u00e0 mettre en \u0153uvre.\nC'est ce qu'avait parfaitement comp ris Anne FagotCampagna qui nous a quitt\u00e9s le 19 janvier 2022.\nElle avait initi\u00e9 et conduit les \u00e9tudes Entred 1 et 2, alors\nqu'elle travaillait \u00e0 l'Institut de veille sanitaire, anc\u00eatre\nde Sant\u00e9 publique France. Elle avait rejoint la S\u00e9curit\u00e9\nsociale il y a dix ans. M\u00e9decin, \u00e0 la fois diab\u00e9tologue\net \u00e9pid\u00e9miologiste, elle savait en effet que l'efficacit\u00e9\nde l'action passe par le d\u00e9veloppement d'une relation\nconstructive entre le financeur, la S\u00e9curit\u00e9 sociale,\net la comm unaut\u00e9 m\u00e9dicale, autour de la question\ncentrale pour l'ave nir de notre syst\u00e8me de sant\u00e9,\nde la pertinence et de la qualit\u00e9 des soins. Il suffit de\nrappeler ici ses travaux sur la chirurgie bariatrique et\nla chirurgie thyro\u00efdienne. Toutes celles et tous ceux\nqui ont eu la chance de la conna\u00eetre ou de travailler\navec elle, gardent le souvenir de sa tr\u00e8s grande\ncomp\u00e9tence et de son extr\u00eame gentillesse. C'\u00e9tait\nune personnalit\u00e9 rayonnante.", "mimetype": "text/plain", "start_char_idx": 1955, "end_char_idx": 4203, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "70deb045-6a17-4c22-8e6e-9b9a81e25550": {"__data__": {"id_": "70deb045-6a17-4c22-8e6e-9b9a81e25550", "embedding": null, "metadata": {"page_label": "383", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a9da3a50-4971-44a3-901a-6f212b5f4210", "node_type": "4", "metadata": {"page_label": "383", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "f14886db27d370426b7b1bea94f37440400f5959289d63a58479e43e77526525", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2f90b85a-8bda-4488-af8c-2d7c23fc9757", "node_type": "1", "metadata": {"page_label": "383", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "5ebd97f40cb918ab22a39445be6df5ef5dd35b45320291884425b5d4ad9b7589", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Il suffit de\nrappeler ici ses travaux sur la chirurgie bariatrique et\nla chirurgie thyro\u00efdienne. Toutes celles et tous ceux\nqui ont eu la chance de la conna\u00eetre ou de travailler\navec elle, gardent le souvenir de sa tr\u00e8s grande\ncomp\u00e9tence et de son extr\u00eame gentillesse. C'\u00e9tait\nune personnalit\u00e9 rayonnante. Le plus bel hommage\nqu'on puisse lui rendre est de poursuivre son \u0153uvre,\ndont Entred fut un volet important.\nMerci \u00e0 tous les investigateurs d'avoir entrepris\net men\u00e9 \u00e0 bien Entred 3, dont les diab\u00e9tologues\nattendent avec impatience les multiples publications\nannonc\u00e9es. \u25a0\nCiter cet article\nGrimaldi A. \u00c9ditorial. Entred 3 est arriv\u00e9 ! Bull Epid\u00e9miol\nHebd. 2022;(22): 382-3.\nbeh/2022/22/2022_22_0.html", "mimetype": "text/plain", "start_char_idx": 3898, "end_char_idx": 4605, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a17a847a-7141-46d1-a3ff-b2d0e454dd5b": {"__data__": {"id_": "a17a847a-7141-46d1-a3ff-b2d0e454dd5b", "embedding": null, "metadata": {"page_label": "384", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d08609ce-3f96-49f5-bf82-9ef617ac3ba2", "node_type": "4", "metadata": {"page_label": "384", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "d1b1b58489d5346c04f7789ef35a8342bf7923a99fefa84d5aa45cbd5e0dff24", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1b3758a4-3124-44d6-8e40-e721a916db70", "node_type": "1", "metadata": {}, "hash": "bfaa7cd0b5132034ce625b1e8a5369a33b6afd6ea47f03497af629d34cd0d79b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "384 | 8 novembre 2022 | BEH 22 Journ\u00e9e mondiale du diab\u00e8te, 14 novembre 2022\npersonnes DT2 : complication coronarienne (18,6%), accident vasculaire c\u00e9r\u00e9bral (7,8%). Ces proportions\n\u00e9taient respectivement de 11,5% et 3,3% pour les personnes DT1.\nDes complications microvasculaires \u00e9taient plus fr\u00e9quemment rapport\u00e9es par les personnes DT1 : perte de\nla vue d 'un \u0153il (3,7%), mal perforant plantaire actif ou ancien (12,9%). Ces proportions \u00e9taient respective -\nment de 3,2% et 6,7% parmi les personnes DT2.\nConclusion - Ces premiers r\u00e9sultats d'Entred 3 apportent un aper\u00e7u des caract\u00e9ristiques et de l'\u00e9tat de\nsant\u00e9 de la population diab\u00e9tique en France. Ils confirment que les caract\u00e9ristiques d\u00e9mographiques et socio -\n\u00e9conomiques sont tr\u00e8s disparates entre le DT1 et le DT2. La l\u00e9g\u00e8re baisse observ\u00e9e, par rapport \u00e0 2007, dans\nla fr\u00e9quence des complications autod\u00e9clar\u00e9es par les personnes DT2 et la fr\u00e9quence \u00e9lev\u00e9e des complications\nmicrovasculaires autod\u00e9clar\u00e9es par les personnes DT1 seront \u00e0 confirmer par des \u00e9tudes approfondies, portant\nnotamment sur les informations recueillies aupr\u00e8s des m\u00e9decins.\nCertaines alertes d\u00e9j\u00e0 \u00e9mises dans les \u00e9ditions pr\u00e9c\u00e9dentes peuvent \u00eatre r\u00e9it\u00e9r\u00e9es : l'ob\u00e9sit\u00e9 et le taba -\ngisme parmi les personnes DT2 restent \u00e0 un niveau tr\u00e8s \u00e9lev\u00e9. Ce niveau est tr\u00e8s \u00e9lev\u00e9 \u00e9galement parmi les\npersonnes DT1 qui conjuguent en outre une fr\u00e9quence \u00e9lev\u00e9e de consommation d 'alcool.\nIntroduction - The third edition of the National Representative Sample of people with Diabetes (ENTRED,\n\u00c9chantillon national t\u00e9moin repr\u00e9sentatif des personnes diab\u00e9tiques), conducted in 2019, aims to describe\nthe characteristics of people with type 2 diabetes (T2D) or type 1 diabetes (T1D) and their health status. This\narticle focuses on the first results self-reported by residents in metropolitan France.\nMethods - A sample of 9072 individuals (\u2265 18 years of age), pharmacologically treated for diabetes, was\nrandomly drawn from the Health Insurance databases (general scheme and social security for the selfemployed). They were asked to complete a self-questionnaire. Data from the National Health Data System\nwere extracted for the entire sample. Weighted estimates were calculated taking into account the sample\ndesign and the the bias of not participating by questionnaire.\nResults - The study population included 8728 individuals, of whom 3166 (36.3%) completed a questionnaire.\nAmong them, 2,714 were identified as having T2D, mean age 67.6 years (+2 years compared to 2007), 55.3%\nwere men (stable/2007), with a median diabetes duration of 10.7 years.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2575, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1b3758a4-3124-44d6-8e40-e721a916db70": {"__data__": {"id_": "1b3758a4-3124-44d6-8e40-e721a916db70", "embedding": null, "metadata": {"page_label": "384", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d08609ce-3f96-49f5-bf82-9ef617ac3ba2", "node_type": "4", "metadata": {"page_label": "384", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "d1b1b58489d5346c04f7789ef35a8342bf7923a99fefa84d5aa45cbd5e0dff24", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a17a847a-7141-46d1-a3ff-b2d0e454dd5b", "node_type": "1", "metadata": {"page_label": "384", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "6f1dc92684fc72e81a8b1a413713b4adb1e736af222925a794af4de99aa51f53", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b1ed2eda-6e70-484e-8f90-8e607dc0e703", "node_type": "1", "metadata": {}, "hash": "cbd16b28b680b07b01795f782e32a89a4667f156d70928c4f60aed66d8b033a7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Results - The study population included 8728 individuals, of whom 3166 (36.3%) completed a questionnaire.\nAmong them, 2,714 were identified as having T2D, mean age 67.6 years (+2 years compared to 2007), 55.3%\nwere men (stable/2007), with a median diabetes duration of 10.7 years. And 412 individuals were identified\nas having T1D, mean age 47 years, 57% were male and 55.6% had diabetes duration \u226520 years. The socio -\neconomic level of T1D individuals was more favorable than that of T2D individuals. Risk factors for compli -\ncations were common in T2D individuals, (overweight/obesity (80.1%), treated hypertension (77.6%), treated\ndyslipidemia (63.8%), smoking (13.4%), heavy or severe alcohol consumption (7%)). They were also common\nin T1D individuals, notably overweight/obesity (49.9%), alcohol consumption (11.3%), and smoking (25.3%).\nMacrovascular complications were more frequently self-reported in T2D: coronary complication (18.6%),\nstroke (7.8%). These proportions were 11.5% and 3.3% respectively for T1D.\nMicrovascular complications were more frequently reported by T1D individuals: loss of sight in one eye (3.7%),\nactive or old foot ulcer (12.9%). These proportions were 3.2% and 6.7% respectively among T2D individuals.\nConclusion - These first results from Entred 3 provide an overview of the characteristics and health status of\nthe diabetic population in France. They confirm the significant disparities in demographic and socioeconomic\ncharacteristics between T1D and T2D .\nThe slight decrease, compared to 2007, in the frequency of self-reported complications in T2D individuals and\nthe high frequency of self-reported microvascular complications in T1D individuals need to be confirmed by\nfurther studies, including information collected from physicians.\nSome warnings already issued in previous editions can be reiterated: obesity and smoking among T2D indi -\nciduals remain at a very high level. This level is also very high among T1D individuals who also have a high\nfrequency of alcohol consumption.\nMots-cl\u00e9s : Diab\u00e8te, Niveau socio\u00e9conomique, Complications, Facteur de risque\n// Keywords: Diabetes, Socioeconomic level, Diabetes complications, Risk factor\nIntroduction\nLe diab\u00e8te est une maladie chronique tr\u00e8s fr\u00e9quente.\nEn France, plus de 3,5 millions de personnes sont\ntrait\u00e9es pharmacologiquement pour un diab\u00e8te (1).\nDans plus de 90% des cas, il s'agi t d'un diab\u00e8te de\ntype 2.", "mimetype": "text/plain", "start_char_idx": 2295, "end_char_idx": 4710, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b1ed2eda-6e70-484e-8f90-8e607dc0e703": {"__data__": {"id_": "b1ed2eda-6e70-484e-8f90-8e607dc0e703", "embedding": null, "metadata": {"page_label": "384", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d08609ce-3f96-49f5-bf82-9ef617ac3ba2", "node_type": "4", "metadata": {"page_label": "384", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "d1b1b58489d5346c04f7789ef35a8342bf7923a99fefa84d5aa45cbd5e0dff24", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1b3758a4-3124-44d6-8e40-e721a916db70", "node_type": "1", "metadata": {"page_label": "384", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "8164b85455da73e34f34048579f3fa31ed1785fac38dea29cba61395aa1132aa", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "En France, plus de 3,5 millions de personnes sont\ntrait\u00e9es pharmacologiquement pour un diab\u00e8te (1).\nDans plus de 90% des cas, il s'agi t d'un diab\u00e8te de\ntype 2. En outre, selon l'\u00e9tu de Esteban (\u00c9tude de\nsant\u00e9 sur l'env ironnement, la biosurveillance, l'act ivit\u00e9 physique et la nutrition), en 2014-2016, 1,2%\ndes adultes m\u00e9tropolitains \u00e2g\u00e9s de 18 \u00e0 74 ans\n(1)\npr\u00e9sentaient un diab\u00e8te et n'\u00e9ta ient pas trait\u00e9s\npharma cologiquement et 1,7% avaient un diab\u00e8te\nm\u00e9connu 1. En cas de cont r\u00f4le insuffisant de la\nmaladie, l'\u00e9volution du diab\u00e8te, qu'il s'agi sse du\ndiab\u00e8te de type 1 ou du diab\u00e8te de type 2, peut \u00eatre\nassoci\u00e9e \u00e0 de graves comp lications. Au-del\u00e0 de\nl'impact sur la qualit\u00e9 de vie des personnes touch\u00e9es\net sur leur esp\u00e9rance de vie, ces comp lications\ninduisent des co\u00fbts en soin \u00e9lev\u00e9s pour le syst\u00e8me\nde sant\u00e9 2. N\u00e9anmoins, des traitements efficaces\nassoci\u00e9s \u00e0 des examens de d\u00e9pistage pr\u00e9coce de\nces complications permettent de retarder, voire", "mimetype": "text/plain", "start_char_idx": 4550, "end_char_idx": 5508, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1f1cd511-86e9-4bee-b8a9-b3911bd7e284": {"__data__": {"id_": "1f1cd511-86e9-4bee-b8a9-b3911bd7e284", "embedding": null, "metadata": {"page_label": "385", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "37a0c2d9-23a3-4f08-b1e6-29e3d0a271d3", "node_type": "4", "metadata": {"page_label": "385", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "76a3c2fa907997b864457a03b6d19293f75907d8de5645904817946b64a02a48", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bc8b22a1-202e-482d-a609-4b6e5c1b3cda", "node_type": "1", "metadata": {}, "hash": "0ee08385b789565dca1517813aaaecc283d60121884b021bfa91461c255717d7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Journ\u00e9e mondiale du diab\u00e8te, 14 novembre 2022 BEH 22 | 8 novembre 2022 | 385\nd'\u00e9viter leur survenue. Ainsi, le diab\u00e8te constitue un\nenjeu de sant\u00e9 publique majeur pour lequel il existe\ndes leviers mobilisables pour r\u00e9duire son fardeau.\nLa surveillance \u00e9pid\u00e9miologique du diab\u00e8te en\nFrance s'est d\u00e9velopp\u00e9e autour des \u00e9tudes Entred\n(\u00c9chantillon national t\u00e9moin repr\u00e9sentatif des per -\nsonnes diab\u00e9tiques), en comp l\u00e9ment des donn\u00e9es\ndisponibles dans le Syst\u00e8me national des donn\u00e9es\nde sant\u00e9 (SNDS). Deux premi\u00e8res \u00e9ditions de\ncette \u00e9tude ont \u00e9t\u00e9 men\u00e9es en 2001 et en 2007 3,\nincluant, pour chacune d'ent re elles, approximati -\nvement 10 000 personnes trait\u00e9es pharmacologi -\nquement pour un diab\u00e8te, s\u00e9lectionn\u00e9es de fa\u00e7on\nal\u00e9atoire dans deux des principaux r\u00e9gimes d'Ass urance maladie en France couvrant pr\u00e8s de 90% de\nla population fran\u00e7aise (le r\u00e9gime g\u00e9n\u00e9ral : RG, et le\nR\u00e9gime social des ind\u00e9pendants : RSI, devenu par\nla suite la S\u00e9curit\u00e9 sociale des ind\u00e9pendants : SSI).\nLes donn\u00e9es d'enqu\u00eates (auto-questionnaires aupr\u00e8s\ndes patients et des m\u00e9decins-soignants) \u00e9taient\ncoupl\u00e9es \u00e0 des donn\u00e9es m\u00e9dico- administratives\n(consommation m\u00e9dicale, donn\u00e9es d'hospitalisation,\nstatut vital et causes m\u00e9dicales de d\u00e9c\u00e8s).\nEn 2007, la deuxi\u00e8me \u00e9dition de l'\u00e9tu de Entred a\nsoulign\u00e9 la consid\u00e9rable am\u00e9lioration de la qualit\u00e9\ndes soins d\u00e9livr\u00e9s aux personnes ayant un diab\u00e8te\nde type 2 (DT2) depuis 2001. Les profils de risque\ncardiovasculaire s'\u00e9taient am\u00e9lior\u00e9s significative -\nment 3-6 . Toutefois, les r\u00e9sultats ont soulign\u00e9 que\ndes am\u00e9liorations sp\u00e9cifiques \u00e9taient encore n\u00e9ces -\nsaires, comme un meilleur d\u00e9pistage et un meilleur\ntraitement des comp lications du diab\u00e8te, particuli\u00e8 -\nrement ophtalmologiques, podologiques et r\u00e9nales.\nDes progr\u00e8s dans le contr\u00f4le des facteurs de risque\n\u00e9taient \u00e9galement n\u00e9cessaires 3-5.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1824, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bc8b22a1-202e-482d-a609-4b6e5c1b3cda": {"__data__": {"id_": "bc8b22a1-202e-482d-a609-4b6e5c1b3cda", "embedding": null, "metadata": {"page_label": "385", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "37a0c2d9-23a3-4f08-b1e6-29e3d0a271d3", "node_type": "4", "metadata": {"page_label": "385", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "76a3c2fa907997b864457a03b6d19293f75907d8de5645904817946b64a02a48", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1f1cd511-86e9-4bee-b8a9-b3911bd7e284", "node_type": "1", "metadata": {"page_label": "385", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "350e4807f8d20e0b13a52a7f23a8e2d1d7efad3f8c9827159deb15dbf8d0b5f1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a835dbdc-ca55-4146-8d33-5c0745b456d4", "node_type": "1", "metadata": {}, "hash": "68d649f80b9fa2cc6e5ff22fd68d33e62cd600e45567b6edf8cd79bc61186406", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Toutefois, les r\u00e9sultats ont soulign\u00e9 que\ndes am\u00e9liorations sp\u00e9cifiques \u00e9taient encore n\u00e9ces -\nsaires, comme un meilleur d\u00e9pistage et un meilleur\ntraitement des comp lications du diab\u00e8te, particuli\u00e8 -\nrement ophtalmologiques, podologiques et r\u00e9nales.\nDes progr\u00e8s dans le contr\u00f4le des facteurs de risque\n\u00e9taient \u00e9galement n\u00e9cessaires 3-5.\nUne troisi\u00e8me \u00e9dition d'Ent red a \u00e9t\u00e9 mise en \u0153uvre\nen 2019 avec comme objectifs principaux :\n1/ de d\u00e9crire et d'\u00e9tudier les \u00e9volutions des caract\u00e9ristiques des personnes trait\u00e9es pharmaco -\nlogiquement pour un diab\u00e8te, notamment leur\nniveau socio\u00e9conomique, leur \u00e9tat de sant\u00e9 li\u00e9\nau diab\u00e8te, le co\u00fbt des soins, le parcours de\nsoins, y compris les d\u00e9marches \u00e9ducatives, la\nqualit\u00e9 des soins, la qualit\u00e9 de vie, la mortalit\u00e9\npar cause sp\u00e9cifique ;\n2/ d'\u00e9tudier les sp\u00e9cificit\u00e9s de certaines popula -\ntions (les personnes ayant un diab\u00e8te de type 1\n(DT1) et les personnes r\u00e9sidant en Guyane,\n\u00e0 l'\u00eele de La R\u00e9union, en Martinique et en\nGuadeloupe) ;\n3/ de produire des donn\u00e9es de r\u00e9f\u00e9rence \u00e0 la\ndisposition de la comm unaut\u00e9 scientifique,\net notamment des programmes de sant\u00e9, afin\nde pouvoir effectuer des comp araisons \u00e0 vis\u00e9e\nd'\u00e9valuation.\nCet article vise \u00e0 d\u00e9crire les caract\u00e9ristiques et l'\u00e9ta t\nde sant\u00e9 des personnes ayant un diab\u00e8te et r\u00e9sidant\nen m\u00e9tropole, en 2019, \u00e0 partir des donn\u00e9es autod\u00e9clar\u00e9es par les personnes ou issues du SNDS.\nM\u00e9thode\n\u00c9tant donn\u00e9 la n\u00e9cessit\u00e9 d'\u00e9tu dier les \u00e9volutions\ntemporelles, chaque \u00e9dition de l'\u00e9tude Entred repose\nsur une m\u00e9thodologie similaire qui associe une\nenqu\u00eate transversale \u00e0 un suivi de cohorte passive.\nLa population source inclut tous les adultes ne vivant\npas en institution ayant b\u00e9n\u00e9fici\u00e9 d'un rembourse -\nment de traitements hypoglyc\u00e9miants oraux ou\ninjectables (classe A10 de la classification ATC\n(anatomique, th\u00e9rapeutique et chimique)) \u00e0 au\nmoins trois dates diff\u00e9rentes au cours des douze\nderniers mois (ou deux dates en cas d'au moins\nun grand cond itionnement), b\u00e9n\u00e9ficiaires d'un des\nr\u00e9gimes de l'Ass urance maladie : RG (y compris\nles sections locales mutualistes infog\u00e9r\u00e9es) et SSI\nen f\u00e9vrier 2019, r\u00e9sidant en France m\u00e9tropolitaine,\ns\u00e9lectionn\u00e9s \u00e0 partir de clefs matriculaires du\nNum\u00e9ro d'inscription au r\u00e9pertoire (NIR) 7.", "mimetype": "text/plain", "start_char_idx": 1487, "end_char_idx": 3720, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a835dbdc-ca55-4146-8d33-5c0745b456d4": {"__data__": {"id_": "a835dbdc-ca55-4146-8d33-5c0745b456d4", "embedding": null, "metadata": {"page_label": "385", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "37a0c2d9-23a3-4f08-b1e6-29e3d0a271d3", "node_type": "4", "metadata": {"page_label": "385", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "76a3c2fa907997b864457a03b6d19293f75907d8de5645904817946b64a02a48", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bc8b22a1-202e-482d-a609-4b6e5c1b3cda", "node_type": "1", "metadata": {"page_label": "385", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "a3a6082957905b2fe7f1369e61330abcd9b64c3dbdb77e6d9a23deb0988a001d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Afin de ne\npas s\u00e9lectionner de personnes ayant \u00e9t\u00e9 incluses\ndans les \u00e9ditions pr\u00e9c\u00e9dentes et, ainsi, de garantir\nl'ind\u00e9pendance des \u00e9chantillons, les clefs matricu -\nlaires utilis\u00e9es dans les \u00e9ditions pr\u00e9c\u00e9dentes avaient\n\u00e9t\u00e9 exclues. \u00c0 partir de cette population source,\nun premier \u00e9chantillon al\u00e9atoire de 8 058 adultes\npr\u00e9sentant un diab\u00e8te a \u00e9t\u00e9 tir\u00e9 au sort. Un \u00e9chan -\ntillon al\u00e9atoire comp l\u00e9mentaire de 1 014 personnes\n\u00e2g\u00e9es de moins de 45 ans sous insuline a \u00e9t\u00e9 tir\u00e9 au\nsort afin de sur-\u00e9chantillonner les personnes ayant\nun DT1.\nL'\u00e9 t u d e comprend quatre phases successives. Apr\u00e8s\navoir \u00e9t\u00e9 inform\u00e9es par un courrier de l'Ass urance\nmaladie de leur s\u00e9lection pour participer \u00e0 Entred 3\net invit\u00e9es \u00e0 r\u00e9pondre \u00e0 un auto-questionnaire par\nInternet ou \u00e0 transmettre leur num\u00e9ro de t\u00e9l\u00e9phone,\nles personnes n'ayant pas refus\u00e9 de participer ont\n\u00e9t\u00e9 contact\u00e9es par une infirmi\u00e8re form\u00e9e (de la plateforme Sophia de l'Ass urance maladie), pour une\nbr\u00e8ve enqu\u00eate t\u00e9l\u00e9phonique. Qu'elles aient particip\u00e9\nou non \u00e0 l'enq u\u00eate t\u00e9l\u00e9phonique, les personnes qui\nn'avaient pas comp l\u00e9t\u00e9 le questionnaire par Internet\nrecevaient un auto-questionnaire d\u00e9taill\u00e9 par voie\npostale.\n\u00c0 la fin des questionnaires, les coordonn\u00e9es des\nm\u00e9decins soignants \u00e9taient recueillies, puis une\nenqu\u00eate m\u00e9dicale par auto-questionnaire postal ou\nInternet \u00e9tait r\u00e9alis\u00e9e aupr\u00e8s de ces derniers, comprenant notamment un recueil de donn\u00e9es cliniques et\nbiologiques.\nEn parall\u00e8le de ces recueils de donn\u00e9es par ques -\ntionnaires, une extraction des donn\u00e9es du SNDS a\n\u00e9t\u00e9 effectu\u00e9e sur une p\u00e9riode de dix ans avant l'inclusion, pour l'ens emble des personnes tir\u00e9es au sort\nqui ne s'y \u00e9taient pas oppos\u00e9es, avec des extractions\nannuelles de donn\u00e9es pr\u00e9vues pour les 10 ann\u00e9es\nsuivantes, soit un recueil pr\u00e9vu sur une p\u00e9riode totale\nde vingt ans. Des indicateurs de cons ommation de\nsoins, tels que m\u00e9dicaments ou actes, ont \u00e9t\u00e9 d\u00e9ve -\nlopp\u00e9s par p\u00e9riode de 12 mois, et des indicateurs\nd'hospitalisation ont \u00e9t\u00e9 d\u00e9velopp\u00e9s sur des p\u00e9riodes\nde 12 mois et \u00e9galement de 10 ans, \u00e0 partir d'alg orithmes publi\u00e9s pr\u00e9c\u00e9demment 8.", "mimetype": "text/plain", "start_char_idx": 3721, "end_char_idx": 5811, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f9180fa7-4324-47cd-a349-4ced7a01da30": {"__data__": {"id_": "f9180fa7-4324-47cd-a349-4ced7a01da30", "embedding": null, "metadata": {"page_label": "386", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4402d63c-bb67-4665-a6c7-816a3f10443f", "node_type": "4", "metadata": {"page_label": "386", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "2ca64f244d6f07d27b64bc2dd52072e693d751714b215fd4881b6f1507807a04", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8b54ddd7-7637-40d9-a640-25073a8a52df", "node_type": "1", "metadata": {}, "hash": "5c7963e7f68c414bf7b56335dffbf1444234b5500ad455ea34e71f4428e4831f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "386 | 8 novembre 2022 | BEH 22 Journ\u00e9e mondiale du diab\u00e8te, 14 novembre 2022\n\u00c0 partir d 'un algorithme \u00e9pid\u00e9miologique d\u00e9ve -\nlopp\u00e9 dans les \u00e9ditions pr\u00e9c\u00e9dentes 9 ainsi que de\nl'ensemble des informations disponibles sur l'his -\ntoire du diab\u00e8te, qu'elles soient recueillies aupr\u00e8s\ndes patients ou, le cas \u00e9ch\u00e9ant, de leurs m\u00e9decins,\nou des indicateurs issus du SNDS, les personnes ont\n\u00e9t\u00e9 class\u00e9es comm e DT1, DT2, ou comm e ayant un\nautre type de diab\u00e8te.\nPar ailleurs, pour chaque personne tir\u00e9e au sort,\ndes informations auxiliaires venaient comp l\u00e9ter\nles extractions du SNDS pour les personnes ne\nles ayant pas refus\u00e9es. Ainsi, les requ\u00eates de\ns\u00e9lection de la population source int\u00e9graient des\nextractions de donn\u00e9es (sexe, \u00e2ge, traitements\nantidiab\u00e9tiques) auxquelles venaient s'ajo uter des\ninformations compl\u00e9mentaires : le g\u00e9ocodage des\nadresses postales \u00e0 l'\u00celo t regroup\u00e9 pour l'inf ormation statistique (Iris), permettant d'ass ocier un indi -\ncateur \u00e9cologique de d\u00e9savantage social (FDep) 10\n\u00e0 une unit\u00e9 g\u00e9ographique relativement fine (quar -\ntier d'environ 2 000 habitants), ainsi que le code du\npays de naissance extrait du num\u00e9ro d'ins cription\nau r\u00e9pertoire (NIR) par l'Ass urance maladie. Ces\ninformations auxiliaires ont permis d'\u00e9tu dier les\ncaract\u00e9ristiques des personnes n'aya nt pas parti -\ncip\u00e9 \u00e0 l'enq u\u00eate par questionnaire sur des crit\u00e8res\nde vuln\u00e9rabilit\u00e9 socio\u00e9conomique, d'\u00e9ta t de sant\u00e9\nou de recours aux soins. Des jeux de pond\u00e9rations\nont ainsi pu \u00eatre d\u00e9velopp\u00e9s tenant comp te \u00e0 la\nfois du plan de sondage et de la non-participation\n\u00e0 l'enqu\u00eate par questionnaire. Afin de comparer les\n\u00e9volutions des estimations avec l'\u00e9di tion men\u00e9e\nen 2007, un second jeu de pond\u00e9ration a \u00e9galement\n\u00e9t\u00e9 d\u00e9velopp\u00e9, bas\u00e9 sur la m\u00e9thodologie utilis\u00e9e\npour Entred 2 9, c'est-\u00e0-dire tenant comp te du plan\nde sondage et de la non-participation selon les\ncrit\u00e8res li\u00e9s au sexe, \u00e0 l'\u00e2ge et aux traitements anti -\ndiab\u00e9tiques uniquement.\nLes estimations sont pr\u00e9sent\u00e9es sous forme de pourcentage ou de moyenne pond\u00e9r\u00e9s, avec un intervalle\nde confiance \u00e0 95% associ\u00e9. Les comparaisons par\nrapport \u00e0 Entred 2 sont pr\u00e9sent\u00e9es en points d'\u00e9vo -\nlution des estimations pond\u00e9r\u00e9es selon la m\u00e9thodo -\nlogie Entred 2.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2222, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8b54ddd7-7637-40d9-a640-25073a8a52df": {"__data__": {"id_": "8b54ddd7-7637-40d9-a640-25073a8a52df", "embedding": null, "metadata": {"page_label": "386", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4402d63c-bb67-4665-a6c7-816a3f10443f", "node_type": "4", "metadata": {"page_label": "386", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "2ca64f244d6f07d27b64bc2dd52072e693d751714b215fd4881b6f1507807a04", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f9180fa7-4324-47cd-a349-4ced7a01da30", "node_type": "1", "metadata": {"page_label": "386", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "4dab18a7378e28f87e07e0d288f5ba6506e73d5525e6aa8ae7deb0d02ca5bd2e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Les estimations sont pr\u00e9sent\u00e9es sous forme de pourcentage ou de moyenne pond\u00e9r\u00e9s, avec un intervalle\nde confiance \u00e0 95% associ\u00e9. Les comparaisons par\nrapport \u00e0 Entred 2 sont pr\u00e9sent\u00e9es en points d'\u00e9vo -\nlution des estimations pond\u00e9r\u00e9es selon la m\u00e9thodo -\nlogie Entred 2.\nR\u00e9sultats\nEn f\u00e9vrier 2019, 9 072 personnes ont \u00e9t\u00e9 s\u00e9lection -\nn\u00e9es pour participer \u00e0 Entred 3, parmi lesquelles 344\nont \u00e9t\u00e9 consid\u00e9r\u00e9es hors champ car elles n'ont pas\npu \u00eatre inform\u00e9es de leur s\u00e9lection dans l'\u00e9tu de\n( courrier retourn\u00e9 non distribu\u00e9, d\u00e9c\u00e8s avant l'env oi\ndu courrier) ou \u00e9taient institutionnalis\u00e9es. Parmi\nles 8 728 personnes consid\u00e9r\u00e9es dans le champ\nde l'enqu\u00eate (figure 1), 3 166 personnes ont parti -\ncip\u00e9 \u00e0 l'enq u\u00eate par questionnaire (36,3%), dont\n2 176 par auto-questionnaire papier, 678 par autoquestionnaire Internet et 312 par questionnaire\nt\u00e9l\u00e9phonique court uniquement. Les comm unes de\nr\u00e9sidence des participants ont \u00e9t\u00e9 cartographi\u00e9es\n(figure 2).\nPar ailleurs, des extractions de donn\u00e9es du SNDS\nont pu \u00eatre effectu\u00e9es pour 93,5% de la population\nd'\u00e9tude, soit 8 138 personnes, 568 personnes s'y\n\u00e9taient oppos\u00e9es et les donn\u00e9es n'ont pas pu \u00eatre\nappari\u00e9es pour 22 personnes.\nParmi les 8 138 personnes de la population d'\u00e9tu de\npour lesquelles un suivi de cohorte passif est\npossible, 55,0% (intervalle de confi ance \u00e0 95% :\nIC95%: [53,8-56,2]) \u00e9taient des hommes, d'un \u00e2ge\nFigure 1\nR\u00e9partition de l'\u00e9chantillon de 9 072 personnes \u00e2g\u00e9es\nde 18 ans et plus, s\u00e9lectionn\u00e9es pour participer\n\u00e0 l'\u00e9tude Entred 3\nTirage au sort\nN=9 072\nPopulation\nd'\u00e9tude\nN=8 728\nHors champ\nN=344\nParticipant\npar questionnaire\nN=3 166*\nSuivi cohorte\npassive\nN=8 138 Questionnaire\ncourt t\u00e9l\u00e9phonique\nuniquement\nN=312\nQuestionnaire\nd\u00e9taill\u00e9\nN=2 854\n* Dont N=3 014 avec un suivi de cohorte passive.\nFigure 2\nCommunes de r\u00e9sidence des participants\npar questionnaire r\u00e9sidant en m\u00e9tropole\npour l'\u00e9tude Entred 3\nSource : Entred 3, Sant\u00e9 publique France, 2022.\nNombre de participants\n(par commune contribuant \u00e0 l'enqu\u00eate)\n[1-5] [6-10] [11-20]", "mimetype": "text/plain", "start_char_idx": 1952, "end_char_idx": 3966, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "45d26c4c-7736-4feb-94c2-166a5a91efc9": {"__data__": {"id_": "45d26c4c-7736-4feb-94c2-166a5a91efc9", "embedding": null, "metadata": {"page_label": "387", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f114a944-4639-4483-8c07-58ae0985d68a", "node_type": "4", "metadata": {"page_label": "387", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "b46d2095d74986d642987e3d9b6a62f267c6df312af829e37c800bb7642ab40c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bd9ee170-52e3-4c2c-9a25-e20908d3ad2b", "node_type": "1", "metadata": {}, "hash": "d857564ebdc3e29e2c405c8a7d12a9d1e4a040b8289fead3cfda4c8033f0e2a6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Journ\u00e9e mondiale du diab\u00e8te, 14 novembre 2022 BEH 22 | 8 novembre 2022 | 387\nmoyen de 66,8 ans [66,5-67,0]. Pr\u00e8s d'un quart d'entre\nelles (24,0% [23,0-25,0]) \u00e9taient n\u00e9es \u00e0 l'\u00e9tr anger,\net dans 11,1% [10,3-11,9] des cas, il s'agissait d'un\npays du Maghreb. Pr\u00e8s d'un quart des personnes\n(23,8% [22,7-24,8]) r\u00e9sidaient dans un Iris faisant\npartie du quintile le plus d\u00e9favoris\u00e9 de France m\u00e9tropolitaine, tandis que 14,7% [13,9-15,6] r\u00e9sidaient dans\nun Iris du quintile le plus favoris\u00e9.\nParmi les 3 166 personnes ayant r\u00e9pondu \u00e0 l'enqu\u00eate,\nquel que soit le mode, 2 714 (94,1% [93,2-94,9]) ont \u00e9t\u00e9\nclass\u00e9es comme DT2, 412 (5,1% [4,4-5,9]) comme DT1,\net 40 (0,8% [0,5-1,2]) ayant un autre type de diab\u00e8te\nou un type ind\u00e9termin\u00e9 par manque d'information.\nCaract\u00e9ristiques sociod\u00e9mographiques\net socio\u00e9conomiques\nLes caract\u00e9ristiques sociod\u00e9mographiques et socio -\n\u00e9conomiques sont pr\u00e9sent\u00e9es dans le tableau 1\nselon le type de diab\u00e8te et illustrent les sp\u00e9cifi -\ncit\u00e9s de ces deux populations. Les personnes DT2\n\u00e9taient principalement des hommes (55,3%), d'un\n\u00e2ge moyen de 67,6 ans, n\u00e9es en France dans\n76,3% des cas et n\u00e9es dans un pays du Maghreb\ndans 11,1% des cas, tandis que les personnes DT1,\n\u00e9galement \u00e0 pr\u00e9dominance masculine (57,2%)\n\u00e9taient plus jeunes, 47 ans en moyenne, et n\u00e9es en\nFrance dans 82,7% des cas.\nTableau 1\nCaract\u00e9ristiques sociod\u00e9mographiques et socio\u00e9conomiques selon le type de diab\u00e8te en 2019, et \u00e9volution depuis 2007\npour les personnes ayant un diab\u00e8te de type 2\nDiab\u00e8te de type 1\n(N=412)\nDiab\u00e8te de type 2\n(DT2) (N=2 714)\n\u00c9volution depuis 2007\n(DT2)\n% IC95% % IC95% Points\nHommes 57,2 [50,3-63,9] 55,3 [53,2-57,5] +0,5\n\u00c2ge moyen (ans) 47,0 [44,9-49,2] 67,6 [67,1-68,1] +1,8\nPays de naissance\nFrance 82,7 [76,5-87,8] 76,3 [74,3-78,2] +0,3\nMaghreb 4,", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1774, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bd9ee170-52e3-4c2c-9a25-e20908d3ad2b": {"__data__": {"id_": "bd9ee170-52e3-4c2c-9a25-e20908d3ad2b", "embedding": null, "metadata": {"page_label": "387", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f114a944-4639-4483-8c07-58ae0985d68a", "node_type": "4", "metadata": {"page_label": "387", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "b46d2095d74986d642987e3d9b6a62f267c6df312af829e37c800bb7642ab40c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "45d26c4c-7736-4feb-94c2-166a5a91efc9", "node_type": "1", "metadata": {"page_label": "387", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "5cc2a1442c85426de180e0e9a35a401ee2924f774f00fc2884d8c3bd0ec57320", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b5a18796-f055-47b8-ab94-fde9b38dcc4a", "node_type": "1", "metadata": {}, "hash": "27b128895f38b8c3a3251fc9c3223ffe35257a2cbdbbfb0bf370c859582cfbb7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3 [53,2-57,5] +0,5\n\u00c2ge moyen (ans) 47,0 [44,9-49,2] 67,6 [67,1-68,1] +1,8\nPays de naissance\nFrance 82,7 [76,5-87,8] 76,3 [74,3-78,2] +0,3\nMaghreb 4,0 [2,3-6,3] 11,1 [9,7-12,7] -0,7\nAutre pays 13,3 [8,5-19,5] 12,6 [11,1-14,2] +0,5\nNiveau d'\u00e9tudes\nJamais scolaris\u00e9(e) 0,8 [0,2-2,2] 3,9 [3,0-5,0] -1,7\nPrimaire non termin\u00e9 0,8 [0,2-2,3] 6,0 [5,0-7,2] -5,6\nPrimaire termin\u00e9, Certificat d'\u00e9tudes primaires 3,0 [0,9-7,1] 23,7 [21,8-25,6] -10,5\nColl\u00e8ge, BEPC, CAP , BEP 37,8 [30,6-45,4] 38,3 [36,2-40,4) +9,2\nLyc\u00e9e, Bac, Bac + 1 an 20,1 [15,3-25,7] 12,4 [11,1-13,9] +3,4\nBac + 2 \u00e0 Bac + 4 ans 22,9 [18,2-28,2] 10,8 [9,6-12,2] +1,0\nBac + 5 ans et plus 14,6 [10,3-19,7] 4,9 [4,1-5,8] +4,3\nDerni\u00e8re profession exerc\u00e9e et cat\u00e9gorie professionnelle*\nArtisans, commer\u00e7ants et chefs d'entreprise 4,6 [2,0-8,8] 7,2 [6,1-8,3] -2,8\nCadres et professions intellectuelles sup\u00e9rieures 14,3 [9,2-20,7] 10,2 [8,9-11,5] +4,6\nProfessions interm\u00e9diaires 21,4 [16,4-27,1] 16,0 [14,1-17,2] -0,5\nEmploy\u00e9s 31,4 [24,8-38,6] 23,5 [21,6-25,5] +3,6\nOuvriers 15,6 [10,7-21,7] 22,6 [20,7-24,5] -3,4\nHommes ou femmes au foyer, ou n'ayant jamais travaill\u00e9 0,8 [0,2-2,2] 6,0 [4,9-7,4] -1,4\nAutres (\u00e9tudiants,", "mimetype": "text/plain", "start_char_idx": 1626, "end_char_idx": 2796, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b5a18796-f055-47b8-ab94-fde9b38dcc4a": {"__data__": {"id_": "b5a18796-f055-47b8-ab94-fde9b38dcc4a", "embedding": null, "metadata": {"page_label": "387", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f114a944-4639-4483-8c07-58ae0985d68a", "node_type": "4", "metadata": {"page_label": "387", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "b46d2095d74986d642987e3d9b6a62f267c6df312af829e37c800bb7642ab40c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bd9ee170-52e3-4c2c-9a25-e20908d3ad2b", "node_type": "1", "metadata": {"page_label": "387", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "a1cbc6972ef4a833e9e80075d926c756059b8ddff39253cfda1d37e6a8cae19a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "6-25,5] +3,6\nOuvriers 15,6 [10,7-21,7] 22,6 [20,7-24,5] -3,4\nHommes ou femmes au foyer, ou n'ayant jamais travaill\u00e9 0,8 [0,2-2,2] 6,0 [4,9-7,4] -1,4\nAutres (\u00e9tudiants, agriculteurs) 3,7 [2,1-6,1] 0,03 [0,0-0,2] -\nManquant 8,2 [4,8-13,0] 14,9 [13,3-16,6] -1,3\nRessenti financier\nVous \u00eates \u00e0 l'aise 14,6 [10,6-19,4] 13,1 [11,7-14,5] +6,4\n\u00c7a va 41,8 [35,1-48,7] 42,7 [40,6-44,8] +5,5\nC'est juste 20,2 [15,3-25,8] 24,8 [22,9-26,7] -7,9\nVous y arrivez difficilement 15,6 [10,2-22,5] 16,1 [14,5-17,8] -3,0\nVous ne pouvez pas y arriver sans faire de dettes 7,8 [3,5-14,6] 3,4 [2,6-4,3] -0,9\nIC95% : intervalle de confiance \u00e0 95%.\n* Information recueillie uniquement dans le questionnaire d\u00e9taill\u00e9.", "mimetype": "text/plain", "start_char_idx": 2629, "end_char_idx": 3319, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "250ad555-4930-43a6-9e26-b66d8986ec27": {"__data__": {"id_": "250ad555-4930-43a6-9e26-b66d8986ec27", "embedding": null, "metadata": {"page_label": "388", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7478fe7e-3fac-43c6-a333-ba873692c862", "node_type": "4", "metadata": {"page_label": "388", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "0719df24b02ce213429aa95ee747b8357fc457916d13a2039a8b4e6fe4014bdd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b0e3fd18-bd56-4710-8e07-ec08b585f0f6", "node_type": "1", "metadata": {}, "hash": "551b35ce8332f502adc36bb12da93d0ca7c0c87d08230eb85e935b45fd3fb342", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "388 | 8 novembre 2022 | BEH 22 Journ\u00e9e mondiale du diab\u00e8te, 14 novembre 2022\nEn termes de niveau socio\u00e9conomique, 34% des\npersonnes DT2 n'avaient pas atteint l'ens eignement\nsecondaire : 10% n'ava ient jamais \u00e9t\u00e9 scolaris\u00e9es\nou n'avaient pas termin\u00e9 l'\u00e9co le primaire et 24%\navaient suivi l'int \u00e9gralit\u00e9 de l'ens eignement primaire\n(versus moins de 5% pour les personnes DT1).\nEnviron 38% des personnes DT2 avaient un niveau\nde scolarit\u00e9 interm\u00e9diaire (coll\u00e8ge ou \u00e9quivalent),\nfr\u00e9quence identique parmi les personnes DT1. Un\npeu plus d'un quart (28,1%) des personnes DT2\navaient atteint le lyc\u00e9e ou un niveau sup\u00e9rieur,\nversus 57,6% des personnes DT1. La r\u00e9partition\ndes professions et cat\u00e9gories professionnelles\n\u00e9tait \u00e9galement diff\u00e9rente entre les personnes DT2\net celles DT1 avec une majorit\u00e9 d'emp loy\u00e9s (31,4%)\net de professions interm\u00e9diaires (21,4%) parmi\nles personnes DT1, tandis que les personnes DT2\n\u00e9taient surtout employ\u00e9s (23,5%) et ouvriers\n(22,6%). Le ressenti financier est plus \u00e9quilibr\u00e9\nentre les personnes DT2 et celles DT1, respective -\nment 55,8% et 56,4% d\u00e9claraient \u00ab \u00e7a va \u00bb ou \u00ab \u00eatre\n\u00e0 l'aise \u00bb financi\u00e8rement.\nPar rapport \u00e0 2007, les personnes DT2 \u00e9taient\nplus \u00e2g\u00e9es de 2 ans, la proportion d'hom mes\n\u00e9tait stable (+0,5 point). Le niveau d'\u00e9tu des avait\naugment\u00e9, avec une proportion de personnes\nayant atteint le niveau lyc\u00e9e ou plus progressant de\npr\u00e8s de 9 points et \u00e0 l'inv erse, celui des personnes\nayant un niveau primaire ou moins r\u00e9gressant de\n18 points. De m\u00eame, le ressenti financier \u00e9tait plus\nfavorable avec une proportion de personnes d\u00e9cla -\nrant \u00ab pas de souci \u00bb progressant de 12 points.\nHistoire de la maladie\nParmi les personnes DT2, l'anc iennet\u00e9 m\u00e9diane\ndu diab\u00e8te auto-d\u00e9clar\u00e9e \u00e9tait de 10,7 ans, et\n21% (19,3-22,8) avaient \u00e9t\u00e9 diagnostiqu\u00e9es depuis\nquatre ans ou moins, 19,7% [18,0-21,4] entre cinq\net neuf ans, 33,7% [31,6-35,7] entre 10 et 19 ans et\n25,6% [23,7-27,6] depuis plus de 20 ans.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1942, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b0e3fd18-bd56-4710-8e07-ec08b585f0f6": {"__data__": {"id_": "b0e3fd18-bd56-4710-8e07-ec08b585f0f6", "embedding": null, "metadata": {"page_label": "388", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7478fe7e-3fac-43c6-a333-ba873692c862", "node_type": "4", "metadata": {"page_label": "388", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "0719df24b02ce213429aa95ee747b8357fc457916d13a2039a8b4e6fe4014bdd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "250ad555-4930-43a6-9e26-b66d8986ec27", "node_type": "1", "metadata": {"page_label": "388", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "4c305fb01e1506722cdd038dd127fed40ce47eed1bdf500d35a103a839324559", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "170eef08-0912-4e13-94f2-cbc9fb8cffc4", "node_type": "1", "metadata": {}, "hash": "023615a8d695d25a05196cefdecf1f74d5543831c16f7016a74ef0e391b229ab", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Par rapport\n\u00e0 2007, le diab\u00e8te \u00e9tait plus ancien (+2 ans en\nm\u00e9diane) avec une \u00e9volution de -8,9 points de la\nproportion de personnes ayant un diab\u00e8te r\u00e9cent,\n-3,8 points pour le diab\u00e8te entre cinq et neuf ans\net +5,5 et +7,2 points pour un diab\u00e8te d\u00e9couvert\nrespectivement entre 10 et 19 ans et 20 ans ou plus.\nDans 70% [67,8-72,0] des cas, ce diab\u00e8te avait \u00e9t\u00e9\nd\u00e9couvert \u00e0 la suite d 'un d\u00e9pistage (+3,3 points par\nrapport \u00e0 2007), et dans 11,7% [10,3-13,3] \u00e0 l'occ asion d'une complication (-3,8 points par rapport \u00e0\n2007). La fr\u00e9quence de d\u00e9couverte sur sympt\u00f4mes\n(18,3% [16,6-20,1]) est rest\u00e9e stable par rapport \u00e0\n2007 (+0,5 point).\nAu cours des 12 derniers mois pr\u00e9c\u00e9dant le tirage\nau sort, 81,6% [79,8-83,3] des personnes DT2\navaient \u00e9t\u00e9 rembours\u00e9es de biguanides. Dans 71,2%\n[69,1-73,2] des cas, les personnes DT2 \u00e9taient trai -\nt\u00e9es uniquement par voie orale (anti diab\u00e9tiques\noraux (ADO)), et pour 34,3% [32,3 -36,4], il s'agissait\nd'une monoth\u00e9rapie. Dans 6,0% [5,1 -7,2] des cas, le\nou les ADO \u00e9taient associ\u00e9s \u00e0 un analogue du GLP1.\nDix-huit pour cent (16,3 -19,8) des personnes DT2\n\u00e9taient trait\u00e9es par insuline associ\u00e9e \u00e0 des ADO\net/ ou un analogue du GLP1. Enfin, 4,5% [3,6-5,5]\n\u00e9taient trait\u00e9es uniquement par insuline.\nPlus de la moiti\u00e9 des personnes DT1 avaient\nun diab\u00e8te diagnostiqu\u00e9 depuis plus de 20 ans\n(55,6% [48,7 -62,3]), ou entre 10 et 19 ans dans\n25,7% [20,4 -31,5] des cas. Seules 8,4% [5,7 -11,6]\ndes personnes DT1 avaient \u00e9t\u00e9 diagnostiqu\u00e9es\nr\u00e9cemment (\u2264 4 ans). Par ailleurs, 36,2% [29,8-43,0]\ndes personnes DT1 avaient \u00e9t\u00e9 rembours\u00e9es d'une\npompe \u00e0 insuline au cours des 12 derniers mois,\net 66% [58,7-72,8] de capteurs pour lecteurs de\nglyc\u00e9mie en continu.", "mimetype": "text/plain", "start_char_idx": 1943, "end_char_idx": 3633, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "170eef08-0912-4e13-94f2-cbc9fb8cffc4": {"__data__": {"id_": "170eef08-0912-4e13-94f2-cbc9fb8cffc4", "embedding": null, "metadata": {"page_label": "388", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7478fe7e-3fac-43c6-a333-ba873692c862", "node_type": "4", "metadata": {"page_label": "388", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "0719df24b02ce213429aa95ee747b8357fc457916d13a2039a8b4e6fe4014bdd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b0e3fd18-bd56-4710-8e07-ec08b585f0f6", "node_type": "1", "metadata": {"page_label": "388", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "651b6578cde1b1993e35ba7873282ba80982e9c96afdd95e025edf3c8f5d6833", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "03e4c841-5144-435b-8498-aa12933ce1e0", "node_type": "1", "metadata": {}, "hash": "08dee1ff9e0ceb630fc4488b507a09f91e1fc18f6b745331cd03cfc0e8962cc7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Par ailleurs, 36,2% [29,8-43,0]\ndes personnes DT1 avaient \u00e9t\u00e9 rembours\u00e9es d'une\npompe \u00e0 insuline au cours des 12 derniers mois,\net 66% [58,7-72,8] de capteurs pour lecteurs de\nglyc\u00e9mie en continu.\nAu cours des 12 derniers mois , 27,3% [21,5 -33,6]\ndes personnes DT1 et 10,6% [9,4-12,0] des\npersonnes DT2 (+2 points par rapport \u00e0 2007) ont \u00e9t\u00e9\nrembours\u00e9es pour une consultation chez un endo -\ncrinologue lib\u00e9ral. Tandis que le nombre m\u00e9dian\nde consultations ou visites en m\u00e9decine g\u00e9n\u00e9 -\nrale sur les 12 mois pr\u00e9c\u00e9dents \u00e9tait de 3,3 pour\nles personnes DT1 et 5,5 pour les personnes DT2\n(-1,3 par rapport \u00e0 2007).\nFacteurs de risque de complications\n\u00c0 l'exception du tabagisme et de la cons ommation\nd'alcool, les facteurs de risque \u00e9taient moins fr\u00e9quents\nchez les personnes DT1 que chez les personnes DT2\n(tableau 2).\nParmi les personnes DT2, l'ind ice de masse\ncorporelle (IMC) moyen \u00e9tait de 29,5 kg/m 2.\nPr\u00e8s de 40% \u00e9taient en surpoids et 40,2%\npr\u00e9sentaient une ob\u00e9sit\u00e9, dont 4% une ob\u00e9sit\u00e9\nmassive ( \u2265 4 0 k g / m2). Une hypertension \u00e9tait\nauto- d\u00e9clar\u00e9e par 61,1% des personnes DT2, un\ntraitement antihypertenseur avait \u00e9t\u00e9 rembours\u00e9\ndans les 12 mois pour 77,6% des personnes.\nUne dyslipid\u00e9mie \u00e9tait auto-d\u00e9clar\u00e9e par 58,8%\ndes personnes DT2, et un traitement hypolip\u00e9 -\nmiant rembours\u00e9 dans les 12 derniers mois chez\n63,8% d'entre elles. Concernant le tabagisme,\nce sont 13,4% des personnes DT2 qui d\u00e9claraient\nfumer occasionnellement ou tous les jours. Enfin,\n7% avaient une cons ommation d'alcool de niveau\n\u00e9lev\u00e9 ou s\u00e9v\u00e8re (selon le score de l'AUDIT-C 11).\nCompar\u00e9s \u00e0 2007, ces facteurs de risque de\ncomplication \u00e9taient stables.\nParmi les personnes DT1, 29,2% \u00e9taient en\nsurpoids, 20,7% \u00e9taient ob\u00e8ses ; 34,2% d\u00e9claraient\nune hypertension, 40,9% \u00e9taient trait\u00e9es par antihypertenseurs ; 31,5% d\u00e9claraient une dyslipid\u00e9mie\net 30,4% \u00e9taient trait\u00e9es par hypolip\u00e9miant. Plus\nd'un quart de la population de DT1 fumait occasion -\nnellement ou quotidiennement (25,3%).", "mimetype": "text/plain", "start_char_idx": 3437, "end_char_idx": 5408, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "03e4c841-5144-435b-8498-aa12933ce1e0": {"__data__": {"id_": "03e4c841-5144-435b-8498-aa12933ce1e0", "embedding": null, "metadata": {"page_label": "388", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7478fe7e-3fac-43c6-a333-ba873692c862", "node_type": "4", "metadata": {"page_label": "388", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "0719df24b02ce213429aa95ee747b8357fc457916d13a2039a8b4e6fe4014bdd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "170eef08-0912-4e13-94f2-cbc9fb8cffc4", "node_type": "1", "metadata": {"page_label": "388", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "1765809ab7abee36f1bace70e8b77ac57703160845664934c116747cd83cf82e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Plus\nd'un quart de la population de DT1 fumait occasion -\nnellement ou quotidiennement (25,3%). Enfin, 7,4%\navaient une cons ommation d'alcool de niveau \u00e9lev\u00e9\net 3,9% s\u00e9v\u00e8re (tableau 2).\nComplications\nLes comp lications macrovasculaires \u00e9taient plus\nfr\u00e9quentes chez les personnes DT2 que chez\nles personnes DT1 (tableau 3). Ainsi, pr\u00e8s de 19%", "mimetype": "text/plain", "start_char_idx": 5313, "end_char_idx": 5655, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7919231f-388c-47f1-b1f1-bcfcea7f1c4e": {"__data__": {"id_": "7919231f-388c-47f1-b1f1-bcfcea7f1c4e", "embedding": null, "metadata": {"page_label": "389", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ea4f9902-39fe-4237-bb1c-9a288b3a7d62", "node_type": "4", "metadata": {"page_label": "389", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "b1f4d710103d927292b9193f69bd0532c0d26a099a278ceb44762edf5fe56a3b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eb22debd-ff37-4548-abaf-d11a0d90cf56", "node_type": "1", "metadata": {}, "hash": "8872dd8a0505d44c0560e84f4e051f1c80f3c892f7bdb696202037540bc138d2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Journ\u00e9e mondiale du diab\u00e8te, 14 novembre 2022 BEH 22 | 8 novembre 2022 | 389\ndes personnes DT2 avaient d\u00e9clar\u00e9 une comp lication coronarienne (infarctus du myocarde (IDM),\nangor, revascularisation coronaire), 3,4% avaient\n\u00e9t\u00e9 hospitalis\u00e9es pour un IDM dans les 10 ans,\n7,8% d\u00e9claraient avoir eu un accident vasculaire\nc\u00e9r\u00e9bral (AVC), et 2,6% avaient eu au moins une\nhospitalisation pour AVC dans les 10 ans. Ces\nproportions \u00e9taient respectivement de 11,5%,\n2,9%, 3,3% et 0% pour les DT1.\n\u00c0 l'inverse, des comp lications microvasculaires\n\u00e9taient davantage rapport\u00e9es par les personnes DT1.\nAinsi, 34,2% auto-d\u00e9claraient une r\u00e9tinopathie, 3,7%\nla perte de la vue d'un \u0153il et 31,0% un traitement au\nlaser, versus respectivement 6,8%, 3,2% et 16,8% des\npersonnes DT2.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 763, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "eb22debd-ff37-4548-abaf-d11a0d90cf56": {"__data__": {"id_": "eb22debd-ff37-4548-abaf-d11a0d90cf56", "embedding": null, "metadata": {"page_label": "389", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ea4f9902-39fe-4237-bb1c-9a288b3a7d62", "node_type": "4", "metadata": {"page_label": "389", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "b1f4d710103d927292b9193f69bd0532c0d26a099a278ceb44762edf5fe56a3b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7919231f-388c-47f1-b1f1-bcfcea7f1c4e", "node_type": "1", "metadata": {"page_label": "389", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "4f1abbd02dd00d631689a1822d8e533a6398b839bac88e077bd015408a20da6c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "21d031ff-af3d-499e-bbd1-a9df85715683", "node_type": "1", "metadata": {}, "hash": "b20d332966592246c9f6e7f44836ea257819ab4beb3f85b1a02088893da77f80", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Concernant les complications podologiques, 12,9% des personnes DT1 d\u00e9claraient un\nmal perforant plantaire actif ou ancien, 2,6% avaient\neffectu\u00e9 au moins un s\u00e9jour hospitalier au cours des\nTableau 2\nFacteurs de risque de complications selon le type de diab\u00e8te en 2019 et variation depuis 2007\npour les personnes ayant un diab\u00e8te de type 2\nDiab\u00e8te de type 1\n(N=412)\nDiab\u00e8te de type 2\n(DT2) (N=2 714)\n\u00c9volution\ndepuis 2007**\n(DT2)% IC95% % IC95%\nCorpulence\nIMC moyen (kg/m2) 26,0 [25,3-26,7] 29,5 [29,2-29,7] +0\nNormal (<25 kg/m\u00b2) 50,1 [43,0-57,2] 19,9 [18,2-21,7] +0,1\nSurpoids (25-29 kg/m\u00b2) 29,2 [23,1-35,8] 39,9 [37,8-42,0] +0,5\nOb\u00e9sit\u00e9 (\u2265 30 kg/m\u00b2) 20,7 [15,0-27,4] 40,2 [38,1-42,3] -0,5\nHTA auto-d\u00e9clar\u00e9e* 34,2 [27,2-41,8] 61,1 [58,9-63,3] +1,4\nTraitement antihypertenseur rembours\u00e9 dans les 12 mois 40,9 [33,7-48,4] 77,6 [75,8-79,4] +0,7\nDyslipid\u00e9mie auto-d\u00e9clar\u00e9e* 31,5 [24,8-38,7] 58,8 [56,5-61,0] +3,6\nTraitement hypolip\u00e9miant rembours\u00e9 dans les 12 mois 30,4 [23,6-37,9] 63,8 [61,7-65,9] +1,4\nTabagisme actuel 25,3 [19,6-31,8) 13,4 [11,9-14,9] -1,1\nConsommation d'alcool*\nFaible 69,0 [61,8-75,6] 76,0 [74,0-77,9] -\nMod\u00e9r\u00e9e 19,6 [14,3-26,0] 17,0 [15,4-18,8] -\n\u00c9lev\u00e9e 7,4 [4,6-11,1] 4,7 [3,8-5,7] -\nS\u00e9v\u00e8re 3,9 [1,01-10,2] 2,3 [1,7-3,0] -\nIC95% : intervalle de confiance \u00e0 95% ; IMC : indice de masse corporelle ; HTA : hypertension art\u00e9rielle.\n* Information recueillie uniquement dans le questionnaire d\u00e9taill\u00e9.", "mimetype": "text/plain", "start_char_idx": 764, "end_char_idx": 2180, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "21d031ff-af3d-499e-bbd1-a9df85715683": {"__data__": {"id_": "21d031ff-af3d-499e-bbd1-a9df85715683", "embedding": null, "metadata": {"page_label": "389", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ea4f9902-39fe-4237-bb1c-9a288b3a7d62", "node_type": "4", "metadata": {"page_label": "389", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "b1f4d710103d927292b9193f69bd0532c0d26a099a278ceb44762edf5fe56a3b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eb22debd-ff37-4548-abaf-d11a0d90cf56", "node_type": "1", "metadata": {"page_label": "389", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "c5adfed87e4ac2aa5cfdce3e73475239c4fb0964cf6283d54eff5e3777aaca9a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "* Information recueillie uniquement dans le questionnaire d\u00e9taill\u00e9.\n** \u00c9volution pr\u00e9sent\u00e9e si l'information \u00e9tait disponible dans Entred 2.\nTableau 3\nComplications selon le type de diab\u00e8te en 2019 et variation depuis 2007 pour les personnes ayant un diab\u00e8te de type 2\nDiab\u00e8te de type 1\n(N=412)\nDiab\u00e8te de type 2\n(DT2) (N=2 714)\n\u00c9volution\ndepuis 2007**\n(DT2)% IC95% % IC95%\nComplication coronarienne auto-d\u00e9clar\u00e9e 11,5 [6,9-17,9] 18,6 [16,9-20,3] -2,4\nHospitalisation pour IDM dans les 10 ans 2,9 [0,5-8,8] 3,4 [2,6-4,3] -\nAnt\u00e9c\u00e9dent d'AVC auto-d\u00e9clar\u00e9 3,3 [1,2-7,1] 7,8 [6,6-9,0] -\nHospitalisation pour AVC dans les 10 ans 0 2,6 [1,9-3,5] -\nR\u00e9tinopathie auto-d\u00e9clar\u00e9e 34,2 [27,3-41,7] 6,8 [5,7-8,0] -\nPerte de la vue d'un \u0153il auto-d\u00e9clar\u00e9e 3,7 [1,6-7,3] 3,2 [2,4-4,1] -0,8\nTraitement au laser auto-d\u00e9clar\u00e9 31,0 [24,3-38,4] 16,8 [15,2-18,5] +1,1\nAnt\u00e9c\u00e9dent de mal perforant plantaire auto-d\u00e9clar\u00e9 12,9 [8,7-18,1] 6,7 [5,7-7,9] -3,4\nHospitalisation pour plaie du pied dans les 10 ans 2,6 [0,8-6,0] 1,6 [1,1-2,3] -\nHospitalisation pour amputation de membre inf\u00e9rieur\ndans les 10 ans 1,2 [0,1-4,3] 0,6 [0,3-1,1] -\nDialyse ou greffe r\u00e9nale dans les 10 ans 1,4 [0,2-4,5] 0,3 [0,1-0,7] -\nIC95% : intervalle de confiance \u00e0 95% ; IDM : infarctus du myocarde ; AVC : accident vasculaire c\u00e9r\u00e9bral.\n** \u00c9volution pr\u00e9sent\u00e9e si l'information \u00e9tait disponible dans Entred 2.", "mimetype": "text/plain", "start_char_idx": 2113, "end_char_idx": 3471, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "35bee021-e562-4031-b71f-04c363aa78dd": {"__data__": {"id_": "35bee021-e562-4031-b71f-04c363aa78dd", "embedding": null, "metadata": {"page_label": "390", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "59c6bb13-f171-460e-a1ca-9659b8619e3e", "node_type": "4", "metadata": {"page_label": "390", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "a10b5381543bb4a03146a0843b699689e5791f1566b22fd85b6f8757ed5df432", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bbf9e1dd-9421-48f9-85b5-5041812e0e79", "node_type": "1", "metadata": {}, "hash": "89e0d605ce7dff49c5a970b53f6342e031a3252123f7660de337d7940e7195c4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "390 | 8 novembre 2022 | BEH 22 Journ\u00e9e mondiale du diab\u00e8te, 14 novembre 2022\n10 ann\u00e9es pr\u00e9c\u00e9dentes pour une plaie du pied et\n1,2% un s\u00e9jour pour une amputation d'un membre\ninf\u00e9rieur. Ces proportions \u00e9taient respectivement de\n6,7%, 1,6% et 0,6% parmi les DT2. Enfin, pour 1,4%\ndes personnes DT1, au moins un s\u00e9jour hospitalier\npour une dialyse ou une greffe r\u00e9nale \u00e9tait retrouv\u00e9\nau cours des 10 ans pr\u00e9c\u00e9dant le tirage au sort. Cette\nproportion \u00e9tait de 0,3% parmi les personnes DT2.\nPar rapport \u00e0 2007, l'auto-d\u00e9claration d'une complication coronarienne parmi les personnes DT2 a\ndiminu\u00e9 de 2,4 points, la perte de la vue d'un \u0153il\nde 0,8 point tandis que la d\u00e9claration d'un mal per -\nforant plantaire a \u00e9galement diminu\u00e9 de 3,4 points.\nDiscussion\nCette troisi\u00e8me \u00e9dition de l'\u00e9tu de Entred a permis\nde d\u00e9crire les caract\u00e9ristiques et l'\u00e9ta t de sant\u00e9\ndes personnes trait\u00e9es pharmacologiquement pour\nun diab\u00e8te en France en 2019 et d'observer les \u00e9volutions dans la population DT2 depuis les \u00e9ditions\npr\u00e9c\u00e9dentes. Pour la premi\u00e8re fois, un sur\u00e9chantil -\nlonnage des personnes DT1 a permis d'apporter des\n\u00e9l\u00e9ments de connaissance sur le diab\u00e8te de type 1\navec une meilleure pr\u00e9cision que celle des \u00e9ditions\nd'Entred pr\u00e9c\u00e9dentes.\nEn France m\u00e9tropolitaine, la population de per -\nsonnes DT2 a vieilli depuis 2007. L '\u00e2ge moyen en\n2019 \u00e9tait de 67 ans alors qu'il \u00e9tait de 65 ans\nen 2007, stable depuis 2001. De m\u00eame, l'anc iennet\u00e9\nm\u00e9diane du diab\u00e8te (11 ans) a augment\u00e9 de 2 ans\nalors qu'elle \u00e9tait stable entre 2001 et 2007. Ce vieil -\nlissement de la population DT2 est probablement\nle reflet de la diminution de l'inc idence du diab\u00e8te\nobserv\u00e9e en France dans une \u00e9tude pr\u00e9c\u00e9dente 12,\ncombin\u00e9e \u00e0 une diminution du taux de mortalit\u00e9\navec un allongement de l'esp\u00e9rance de vie des per -\nsonnes ayant un diab\u00e8te observ\u00e9 \u00e0 partir du suivi\nde mortalit\u00e9 effectu\u00e9 dans les pr\u00e9c\u00e9dentes \u00e9ditions\nd'Entred 13.\nLe niveau socio\u00e9conomique des personnes DT2\na \u00e9volu\u00e9 avec une progression du niveau d'\u00e9tu de\ndepuis 2007, qui refl\u00e8te probablement un effet\ng\u00e9n\u00e9rationnel avec une augmentation du niveau\nd'\u00e9tude observ\u00e9e dans l'ens emble de la population\nfran\u00e7aise.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2147, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bbf9e1dd-9421-48f9-85b5-5041812e0e79": {"__data__": {"id_": "bbf9e1dd-9421-48f9-85b5-5041812e0e79", "embedding": null, "metadata": {"page_label": "390", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "59c6bb13-f171-460e-a1ca-9659b8619e3e", "node_type": "4", "metadata": {"page_label": "390", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "a10b5381543bb4a03146a0843b699689e5791f1566b22fd85b6f8757ed5df432", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "35bee021-e562-4031-b71f-04c363aa78dd", "node_type": "1", "metadata": {"page_label": "390", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "7bd4013fe964d45cdf7b4bd8c2b8fcde604b4ecab552f048b12699c9081d820f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "42b2f301-3c13-487d-acfc-47c718e50dd0", "node_type": "1", "metadata": {}, "hash": "2784eb7283dce7a3bcaf05f16c112a7aea93287adfd73859860b7410a3a99783", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Le niveau socio\u00e9conomique des personnes DT2\na \u00e9volu\u00e9 avec une progression du niveau d'\u00e9tu de\ndepuis 2007, qui refl\u00e8te probablement un effet\ng\u00e9n\u00e9rationnel avec une augmentation du niveau\nd'\u00e9tude observ\u00e9e dans l'ens emble de la population\nfran\u00e7aise.\nSi une accentuation de l'ob\u00e9 sit\u00e9 avait \u00e9t\u00e9 objec -\ntiv\u00e9e entre 2001 et 2007, celle-ci s'est stabilis\u00e9e\nen 2019 avec une fr\u00e9quence de l'ob\u00e9 sit\u00e9 qui reste\ntr\u00e8s \u00e9lev\u00e9e et conc erne plus de 40% de la popu -\nlation DT2, et une m\u00eame proportion de personnes\nen surpoids. De m\u00eame, le tabagisme s'est stabilis\u00e9\ndepuis 2007, \u00e0 un niveau \u00e9lev\u00e9 (13%, -1 point) pour\nune population \u00e0 tr\u00e8s haut risque de comp lications\ncardiovasculaires. Ces gains potentiels d'am\u00e9 lioration avaient d\u00e9j\u00e0 \u00e9t\u00e9 mis en \u00e9vidence dans l'\u00e9di -\ntion pr\u00e9c\u00e9dente d'Ent red, sans que la situation ait\n\u00e9volu\u00e9 depuis.\nEnfin, une hypertension et une dyslipid\u00e9mie \u00e9taient\nd\u00e9clar\u00e9es par environ 60% des personnes, et des\ntraitements antihypertenseurs ou hypolip\u00e9miants\n\u00e9taient rembours\u00e9s au cours des 12 derniers mois \u00e0\nrespectivement 78% et 64% des personnes. Il sera\ntoutefois n\u00e9cessaire de comp l\u00e9ter ces informations\navec les valeurs de pression art\u00e9rielle et de lipid\u00e9 -\nmies recueillies aupr\u00e8s des m\u00e9decins pour objec -\ntiver l'\u00e9volution du niveau de cont r\u00f4le du risque\nvasculaire. De m\u00eame, les valeurs d'HbA1c (h\u00e9mo -\nglobine glyqu\u00e9e) recueillies aupr\u00e8s des m\u00e9de -\ncins permettront d'\u00e9tudier l'\u00e9volution de l'\u00e9quilibre\nglyc\u00e9mique.\nConcernant les comp lications, les premi\u00e8res infor -\nmations auto-d\u00e9clar\u00e9es par les personnes rapportent\nune pr\u00e9valence de complications microvasculaires et\nmacrovasculaires relativement \u00e9lev\u00e9e, mais en dimi -\nnution par rapport \u00e0 2007. N\u00e9anmoins, il sera impor -\ntant d'\u00e9tudier les \u00e9volutions temporelles, \u00e0 histoire de\nla maladie et caract\u00e9ristiques socio- \u00e9conomiques et\nsociod\u00e9mographiques \u00e9quivalentes, pour conclure\n\u00e0 une v\u00e9ritable am\u00e9lioration de l'\u00e9ta t de sant\u00e9\ndes personnes DT2. Les donn\u00e9es recueillies aupr\u00e8s\ndes m\u00e9decins apporteront \u00e9galement des comp l\u00e9ments d'information.", "mimetype": "text/plain", "start_char_idx": 1900, "end_char_idx": 3931, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "42b2f301-3c13-487d-acfc-47c718e50dd0": {"__data__": {"id_": "42b2f301-3c13-487d-acfc-47c718e50dd0", "embedding": null, "metadata": {"page_label": "390", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "59c6bb13-f171-460e-a1ca-9659b8619e3e", "node_type": "4", "metadata": {"page_label": "390", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "a10b5381543bb4a03146a0843b699689e5791f1566b22fd85b6f8757ed5df432", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bbf9e1dd-9421-48f9-85b5-5041812e0e79", "node_type": "1", "metadata": {"page_label": "390", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "12cbd2aaf9a2bee7e2c7199ad9ff8f20fbcc6b54bba5114ccf47756dd75c3b16", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Les donn\u00e9es recueillies aupr\u00e8s\ndes m\u00e9decins apporteront \u00e9galement des comp l\u00e9ments d'information. Par ailleurs, les donn\u00e9es d'hos -\npitalisation issues du SNDS rapportent de nouvelles\ninformations objectives non disponibles dans les\n\u00e9ditions pr\u00e9c\u00e9dentes : l'incidence des complications\ngraves sur une p\u00e9riode de dix ans pour les IDM, les\nAVC, les amputations et l'ins uffisance r\u00e9nale chro -\nnique terminale. Ces nouvelles donn\u00e9es pourront\n\u00e9galement \u00eatre suivies sur une p\u00e9riode prospective\nde dix ans.\nEn termes de m\u00e9thodologie d'enq u\u00eate, les donn\u00e9es\ndu SNDS permettent \u00e9galement de disposer d'inf ormations pr\u00e9cieuses sur les personnes n'aya nt pas\nparticip\u00e9 \u00e0 l'enq u\u00eate par questionnaires et ainsi\nd'approfondir l'\u00e9tude de la non-participation. La prise\nen compte de ces informations dans les jeux de\npond\u00e9ration permet de limiter les biais de s\u00e9lection.\nAinsi, tout en cons ervant une m\u00e9thodologie simi -\nlaire \u00e0 celle utilis\u00e9e dans les \u00e9ditions pr\u00e9c\u00e9dentes,\nEntred 3 a pu b\u00e9n\u00e9ficier des avanc\u00e9es technolo -\ngiques survenues au cours de la derni\u00e8re d\u00e9cennie\nen mati\u00e8re de syst\u00e8mes d'inf ormation avec le d\u00e9ve -\nloppement du SNDS.\nCes premiers r\u00e9sultats permettent \u00e9galement de\nmettre en perspective, de comparer, les informations\nconcernant les personnes DT1 et les personnes DT2.\nLa taille de notre \u00e9chantillon de personnes DT1\npermet une description plus pr\u00e9cise de cette popu -\nlation et met en lumi\u00e8re ses sp\u00e9cificit\u00e9s , ainsi que\ncelles de la pathologie qui les affecte . Ainsi, malgr\u00e9\nleur plus jeune \u00e2ge, plus de la moiti\u00e9 des adultes DT1\nont un diab\u00e8te datant de plus de vingt ans et un\nniveau socio\u00e9conomique plus favorable que celui\ndes personnes DT2. Les facteurs de risque de\ncomplications vasculaires sont fr\u00e9quents parmi les\nDT1, et notamment le surpoids incluant l'ob\u00e9 sit\u00e9\npour plus de la moiti\u00e9 de la population, et le taba -\ngisme d\u00e9clar\u00e9 par un quart d'ent re eux. Par ailleurs,\nsi les comp lications macrovasculaires sont moins\nfr\u00e9quentes chez les personnes DT1 que pour\nles personnes DT2, la pr\u00e9valence des complications\nmicrovasculaires est tr\u00e8s \u00e9lev\u00e9e, qu'il s'agi sse des", "mimetype": "text/plain", "start_char_idx": 3834, "end_char_idx": 5935, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1ab76d8f-58a7-4141-ba7e-931fc48c8a44": {"__data__": {"id_": "1ab76d8f-58a7-4141-ba7e-931fc48c8a44", "embedding": null, "metadata": {"page_label": "391", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9b5a05a3-6a2a-4f98-9d16-ff2d8f98b294", "node_type": "4", "metadata": {"page_label": "391", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "a48df3ff7deca7f4c3016ed0b522fa588c7107a6b89f86dfb7e32b46a18c983b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "82a3716d-4285-4456-b7dc-856f97b2e57c", "node_type": "1", "metadata": {}, "hash": "4983a972d169dbb3d017d5e3b3648e652a90a8f99414765ac8fc1beed6a12f2d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Journ\u00e9e mondiale du diab\u00e8te, 14 novembre 2022 BEH 22 | 8 novembre 2022 | 391\ncomplications ophtalmologiques, podologiques ou\nr\u00e9nales. Les donn\u00e9es recueillies aupr\u00e8s des m\u00e9de -\ncins permettront de confi rmer ces informations qui\npeuvent \u00eatre sujettes \u00e0 des biais de d\u00e9claration et\npermettront d'affiner ces premiers r\u00e9sultats.\nConclusion\nCes premiers r\u00e9sultats de la 3 e \u00e9dition de l'\u00e9tu de\nEntred nous apportent une description des caract\u00e9 -\nristiques et de l'\u00e9tat de sant\u00e9 de la population diab\u00e9tique de France m\u00e9tropolitaine en 2019, globalement\net selon le type de diab\u00e8te. Il est \u00e0 pr\u00e9sent n\u00e9ces -\nsaire de comp l\u00e9ter ces \u00e9l\u00e9ments par les informa -\ntions recueillies aupr\u00e8s des m\u00e9decins, afin d'affi ner\nl'\u00e9tude des comp lications et d'app orter des infor -\nmations sur le niveau de de cont r\u00f4le des facteurs\nde risque de comp lications, notamment l'\u00e9qu ilibre\nglyc\u00e9mique.\nD'autres analyses sont \u00e9galement \u00e0 venir pour\napporter des \u00e9l\u00e9ments de connaissance sur la\nqualit\u00e9 de vie, le recours aux soins, le recours aux\nnouveaux dispositifs et outils connect\u00e9s, les comp lications aigu\u00ebs, l'observance th\u00e9rapeutique, le reten -\ntissement professionnel, familial, social du diab\u00e8te, la\nlitt\u00e9ratie en sant\u00e9...\nUne description de l'\u00e9ta t de sant\u00e9 des personnes\npr\u00e9sentant un diab\u00e8te r\u00e9sidant dans les d\u00e9parte -\nments d'outre-mer sera \u00e9galement propos\u00e9e gr\u00e2ce\n\u00e0 un recueil de donn\u00e9es effectu\u00e9 aupr\u00e8s de plus de\n2 300 personnes.\nL 'ensemble de ces informations permettront de\ndocumenter les politiques publiques pour des orien -\ntations en mati\u00e8re de pr\u00e9vention, d'accompagnement\net de prise en charge des personnes pr\u00e9sentant un\ndiab\u00e8te. \u25a0\nRemerciements\nNous remercions chaleureusement les personnes et leurs\nm\u00e9decins qui ont g\u00e9n\u00e9reusement particip\u00e9 \u00e0 l'\u00e9tude.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1757, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "82a3716d-4285-4456-b7dc-856f97b2e57c": {"__data__": {"id_": "82a3716d-4285-4456-b7dc-856f97b2e57c", "embedding": null, "metadata": {"page_label": "391", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9b5a05a3-6a2a-4f98-9d16-ff2d8f98b294", "node_type": "4", "metadata": {"page_label": "391", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "a48df3ff7deca7f4c3016ed0b522fa588c7107a6b89f86dfb7e32b46a18c983b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1ab76d8f-58a7-4141-ba7e-931fc48c8a44", "node_type": "1", "metadata": {"page_label": "391", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "83dd72595db2aac1f7b499021d78b31d56187c5b63dad20efca5a22338551f72", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6d5ca368-bf0a-4999-8105-a2cf33baf7c3", "node_type": "1", "metadata": {}, "hash": "bf3b7d805dbf652601838a50fb5988785d1a48a25e5978b234db9252386abca1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "L 'ensemble de ces informations permettront de\ndocumenter les politiques publiques pour des orien -\ntations en mati\u00e8re de pr\u00e9vention, d'accompagnement\net de prise en charge des personnes pr\u00e9sentant un\ndiab\u00e8te. \u25a0\nRemerciements\nNous remercions chaleureusement les personnes et leurs\nm\u00e9decins qui ont g\u00e9n\u00e9reusement particip\u00e9 \u00e0 l'\u00e9tude.\nNous tenons \u00e9galement \u00e0 remercier toutes les personnes qui\nont contribu\u00e9 \u00e0 la collecte des donn\u00e9es : le service Sophia\nde l'Assurance maladie; les \u00e9quipes d'Ipsos, notamment\nEmmanuelle Hoingne, Nathan Jeandet et Val\u00e9rie Blineau ;\nl'\u00e9quipe projet Entred 3 de Sant\u00e9 publique France, notam -\nment les charg\u00e9s d'\u00e9tude Emmanuelle Szego, Val\u00e9rie Henry,\nJessica Gane, C\u00e9line Lavalette et Pascal Bessonneau,\nPerrine de Crouy-Chanel qui a r\u00e9alis\u00e9 les cartes ; ainsi\nque Marjorie Boussac et David Dias de la Caisse nationale\nd'assurance maladie, qui ont proc\u00e9d\u00e9 aux extractions des\ndonn\u00e9es du SNDS ; Anne-Lyne Couillerot (Haute Autorit\u00e9\nde sant\u00e9), Hayat Bourezane (SSI), C\u00e9line Druet (Agence\nnationale de s\u00e9curit\u00e9 sanitaire de l'alimentation, de l'envi -\nronnement et du travail), et toutes les personnes qui ont\nparticip\u00e9 \u00e0 la mise en \u0153uvre de l'\u00e9tude. Enfin, nous tenons\n\u00e0 remercier les nombreux experts qui ont contribu\u00e9 \u00e0 cette\n\u00e9tude dans le cadre du Comit\u00e9 scientifique, du Comit\u00e9\nd'interface diab\u00e8te de Sant\u00e9 publique France ainsi que la\nF\u00e9d\u00e9ration fran\u00e7aise des diab\u00e9tiques, la Soci\u00e9t\u00e9 franco -\nphone du diab\u00e8te et le Coll\u00e8ge de la m\u00e9decine g\u00e9n\u00e9rale\npour leur soutien.\nNous souhaitons \u00e9galement rendre un hommage chaleu -\nreux \u00e0 Michelle Chantry qui nous a quitt\u00e9s en juillet dernier.\nEn tant que cheffe de projet d'Entred pour la Cnam, Michelle\na eu un r\u00f4le essentiel dans cette \u00e9tude et dans les \u00e9ditions\npr\u00e9c\u00e9 dentes, notamment en d\u00e9veloppant les requ\u00eates de\ns\u00e9lection des participants. Michelle a donc \u00e9t\u00e9 un acteur clef\nde la r\u00e9ussite de ce dispositif d'\u00e9tudes.\nLiens d'int\u00e9r\u00eat\nLes auteurs d\u00e9clarent n'avoir aucun lien d'int\u00e9r\u00eat au regard du\ncontenu de l'article.\nR\u00e9f\u00e9rences\n[1] Lailler G, Piffaretti C, Fuentes S, Nabe HD, Oleko A,\nCosson E, et al . Prevalence of prediabetes and undia -\ngnosed type 2 diabetes in France: Results from the national\nsurvey Esteban, 2014-2016. Diabetes Res Clin Pract. 2020;\n165:108252.\n[2] Am\u00e9liorer la qualit\u00e9 du syst\u00e8me de sant\u00e9 et ma\u00eetriser les\nd\u00e9penses.", "mimetype": "text/plain", "start_char_idx": 1425, "end_char_idx": 3750, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6d5ca368-bf0a-4999-8105-a2cf33baf7c3": {"__data__": {"id_": "6d5ca368-bf0a-4999-8105-a2cf33baf7c3", "embedding": null, "metadata": {"page_label": "391", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9b5a05a3-6a2a-4f98-9d16-ff2d8f98b294", "node_type": "4", "metadata": {"page_label": "391", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "a48df3ff7deca7f4c3016ed0b522fa588c7107a6b89f86dfb7e32b46a18c983b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "82a3716d-4285-4456-b7dc-856f97b2e57c", "node_type": "1", "metadata": {"page_label": "391", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "4e5d55e34f2c10609918d190f730536f6cf01aada10f74079e909a217f1f0765", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bd1f66a1-be73-4092-9c49-218bf182b7e2", "node_type": "1", "metadata": {}, "hash": "9d08e1fb5e2fdbcb2039320c516c9455d483472c726d69ed83c006aea093d3ba", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Prevalence of prediabetes and undia -\ngnosed type 2 diabetes in France: Results from the national\nsurvey Esteban, 2014-2016. Diabetes Res Clin Pract. 2020;\n165:108252.\n[2] Am\u00e9liorer la qualit\u00e9 du syst\u00e8me de sant\u00e9 et ma\u00eetriser les\nd\u00e9penses. Propositions de l'Assurance maladie pour 2017.\nParis: CnamTS; 2016. 178 p.\nfr/etudes-et-donnees/2016-rapport-propositions-pour-2017charges-produits\n[3] Fagot-Campagna A, Fosse S, Roudier C, Romon I,\nPenfornis A, Lecomte P, et al . Caract\u00e9ristiques, risque\nvasculaire et complications chez les personnes diab\u00e9 -\ntiques en France m\u00e9tropolitaine : d'importantes \u00e9volutions\nentre Entred 2001 et Entred 2007. Bull \u00c9pidemiol Hebd.\n2009;(42-43):450-5.\ndies-et-traumatismes/diabete/documents/article/caracte\nristiques-risque-vasculaire-et-complica tions-chez-les-per\nsonnes-diabetiques-en-france-metropoli taine-d-impor\ntantes-evolutions-entre-entre2\n[4] Assogba FG, Couchoud C, Roudier C, Pornet C, Fosse S,\nRomon I, et al. Prevalence, screening and treatment of chronic\nkidney disease in people with type 2 diabetes in France.\nThe ENTRED surveys (2001 and 2007). Diabetes Metab.\n2012;38(6):558-66.\n[5] Pornet C, Bourdel-Marchasson I, Lecomte P, Eschwege E,\nRomon I, Fosse S, et al. Trends in the quality of care for elderly\npeople with type 2 diabetes: The need for improvements in\nsafety and quality (the 2001 and 2007 ENTRED Surveys).\nDiabetes Metab. 2011;37(2):152-61.\n[6] Druet C, Roudier C, Romon I, Assogba FG, BourdelMarchasson I, et al. \u00c9chantillon national t\u00e9moin repr\u00e9sentatif\ndes personnes diab\u00e9tiques, Entred 2007-2010. Caract\u00e9ris -\ntiques, \u00e9tat de sant\u00e9, prise en charge et poids \u00e9conomique\ndes personnes diab\u00e9tiques. Saint-Maurice: Institut de veille\nsanitaire; 2012. 8 p.\ndies-et-traumatismes/diabete/documents/rapport-synthese/\nechantillon-national-temoin-representatif-des-personnesdiabetiques-entred-2007-2010.-caracteristiques-etat-desante-prise-en-charge-et-poids-ec\n[7] Tuppin P, Rudant J, Constantinou P, Gastaldi-M\u00e9nager C,\nRachas A, de Roquefeuil L, et al .", "mimetype": "text/plain", "start_char_idx": 3511, "end_char_idx": 5526, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bd1f66a1-be73-4092-9c49-218bf182b7e2": {"__data__": {"id_": "bd1f66a1-be73-4092-9c49-218bf182b7e2", "embedding": null, "metadata": {"page_label": "391", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9b5a05a3-6a2a-4f98-9d16-ff2d8f98b294", "node_type": "4", "metadata": {"page_label": "391", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "a48df3ff7deca7f4c3016ed0b522fa588c7107a6b89f86dfb7e32b46a18c983b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6d5ca368-bf0a-4999-8105-a2cf33baf7c3", "node_type": "1", "metadata": {"page_label": "391", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "ec90213bb7814c6b4484b45aa8b69fd62a83f5da5d3d017f88020c2205cc45fe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Value of a national adminis -\ntrative database to guide public decisions: From the syst\u00e8me\nnational d'information interr\u00e9gimes de l'Assurance aladie\n(SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9\n(SNDS) in France. Revue Epidemiol Sante Publique. 2017;65\nSuppl 4:S149-S167.\n[8] Fosse-Edorh S, Mandereau-Bruno L, Regnault N. Le poids\ndes complications li\u00e9es au diab\u00e8te en France en 2013. Synth\u00e8se\net perspectives. Bull \u00c9pidemiol Hebd. 2015(34-35):619-25. http://\nbeh.santepubliquefrance.fr/beh/2015/34-35/2015_34-35_1.html\n[9] Fosse S, Romon I, Druet C, Fagot-Campagna A. \u00c9chan -\ntillon national t\u00e9moin repr\u00e9sentatif des personnes diab\u00e9tiques,\nEntred 2007-2010. Rapport m\u00e9thodologique. Saint-Maurice:\nInstitut de veille sanitaire; 2012. 73 p.\nquefrance.fr/maladies-et-traumatismes/diabete/documents/\nrapport-synthese/echantillon-natio nal-temoin-representatifdes-personnes-diabetiques-en tred-2007-2010.-rapport-metho\ndologique", "mimetype": "text/plain", "start_char_idx": 5527, "end_char_idx": 6460, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "29093c73-7f46-49cf-bbb2-ae3a45493067": {"__data__": {"id_": "29093c73-7f46-49cf-bbb2-ae3a45493067", "embedding": null, "metadata": {"page_label": "392", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a3ae29db-75c0-4746-a6a7-ca7082669b01", "node_type": "4", "metadata": {"page_label": "392", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "95742f1bfe203c67154af278904dab9b584815141333fcbff2e5d606ca9d97fd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cd6991e9-3d22-4b82-a0c8-b02abff188ee", "node_type": "1", "metadata": {}, "hash": "cc8428006afa9e9eb6579d54371faa01fbe5ce57f8ba391a2d681fa4a9ea0f5b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "392 | 8 novembre 2022 | BEH 22 Journ\u00e9e mondiale du diab\u00e8te, 14 novembre 2022\nARTICLE // Article\nTABAGISME ET DIAB\u00c8TE : LE TEMPS DE L'ACTION\n// SMOKING AND DIABETES: TIME FOR ACTION\nVincent Durlach (), pour le groupe de travail Tabagisme et diab\u00e8te*\nUniversit\u00e9 Reims Champagne-Ardenne, UMR CNRS 7369 MEDyC, P\u00f4le Cardio-Thoracique, Centre hospitalier universitaire\nde Reims\n* Vincent Durlach, Bruno Verg\u00e8s, Abdallah Al-Salameh, Thibault Bahougne, Farid Benzerouk, Ivan Berlin, Carole Clair, Jacques\nMansourati, Alexia Rouland, St\u00e9phanie Genou-Vannobel, Isabelle Gaudy, Daniel Thomas, Philippe Thuillier, Laura Phirmis,\nClaude Chaumeil, Blandine Tramunt, Anne-Laurence Le Faou\nSoumis le 02.08.2022 // Date of submission: 08.02.2022\nR\u00e9sum\u00e9 // Abstract\nLes \u00e9tudes \u00e9pid\u00e9miologiques montrent un lien clair entre tabagisme (actif ou passif) et le risque de d\u00e9velopper\nun diab\u00e8te de type 2 (DT2). Le tabagisme majore la mortalit\u00e9 toutes causes ainsi que le risque de complications\nmacro- et micro-angiopathiques (n\u00e9phropathie chez le patient DT2, r\u00e9tinopathie et neuropathie chez le diab\u00e9 -\ntique de type 1), il participe au d\u00e9s\u00e9quilibre glyc\u00e9mique et favorise le diab\u00e8te gestationnel. Pr\u00e9venir le tabagisme\nchez le sujet \u00e0 risque de DT2 et promouvoir le sevrage tabagique chez le patient DT2 constituent donc une priorit\u00e9 de sant\u00e9 publique selon un r\u00e9cent consensus d'experts publi\u00e9 par la Soci\u00e9t\u00e9 francophone de tabacologie\n(SFT) et la Soci\u00e9t\u00e9 francophone du diab\u00e8te (SFD).\nEpidemiologic studies demonstrate a clear link between active or passive smoking and the risk of developing a\ntype 2 diabetes (T2D). Cigarette smoking increases all-cause mortality as well as the risk of macro and micro -\nvascular complications (i.e. nephropathy in T2D patient , retinopathy and neuropathy in type 1 diabetes), it alters\nglycemic control and favours gestational diabetes mellitus. Preventing cigarette smoking in patients at risk of\nT2D and promoting smoking cessation in T2D patients are public health priorities, as recently concluded in a\njoint position statement by the French-Speaking Society on Tobacco (Soci\u00e9t\u00e9 francophone de tabacologie) and\nthe French-Speaking Society of Diabetes (Soci\u00e9t\u00e9 francophone du diab\u00e8te).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2207, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cd6991e9-3d22-4b82-a0c8-b02abff188ee": {"__data__": {"id_": "cd6991e9-3d22-4b82-a0c8-b02abff188ee", "embedding": null, "metadata": {"page_label": "392", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a3ae29db-75c0-4746-a6a7-ca7082669b01", "node_type": "4", "metadata": {"page_label": "392", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "95742f1bfe203c67154af278904dab9b584815141333fcbff2e5d606ca9d97fd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "29093c73-7f46-49cf-bbb2-ae3a45493067", "node_type": "1", "metadata": {"page_label": "392", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "e06f0542484f79549a9d01cc4413643a39a7a2871e32904b1b0ab542ead0f29d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ec558eee-5f8a-4269-a304-2b93d23268ce", "node_type": "1", "metadata": {}, "hash": "9246d2dd9285d72bfe763d26931d6b36f4f06f39d2b9c7d95bf43ff67fa57259", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Preventing cigarette smoking in patients at risk of\nT2D and promoting smoking cessation in T2D patients are public health priorities, as recently concluded in a\njoint position statement by the French-Speaking Society on Tobacco (Soci\u00e9t\u00e9 francophone de tabacologie) and\nthe French-Speaking Society of Diabetes (Soci\u00e9t\u00e9 francophone du diab\u00e8te).\nMots-cl\u00e9s : Diab\u00e8te, Tabagisme, Maladies chroniques, Relation causale, Complications, Sevrage tabagique\n// Keywords: Diabetes, Smoking, Chronic diseases, Causal relationship, Diabetes complications, Smoking cessation\nIntroduction\nLe diab\u00e8te de type 2 (DT2) et le tabagisme s'inscrivent\ndans le champ des maladies chroniques et cons tituent deux probl\u00e8mes de sant\u00e9 publique majeurs ;\nils r\u00e9duisent l'un et l'aut re sensiblement l'esp \u00e9rance\nde vie (10 ans en moyenne pour le tabagisme, 6 ans\npour le DT2) et \u00e9voluent de mani\u00e8re \u00e9pid\u00e9mique 1.\nPlus de 1 milliard d'hommes et 250 millions de femmes\nfument et l'\u00e9volution du diab\u00e8te est \u00e9pid\u00e9mique (touchant\nplus de 537 millions d'individus en 2021). Le DT2 est\nle plus fr\u00e9quent, son \u00e9volution est satellite de celle de\nl'ob\u00e9sit\u00e9 abdominale touchant de 4 \u00e0 10 % de la population 2. La pr\u00e9valence du tabagisme dans le monde est\nde l'ordre de 20,8% chez la personne DT2 et varie selon\n>\nVincent Durlach\nUniversit\u00e9 Reims Champagne-Ardenne, UMR CNRS 7369 MEDyC, P\u00f4le Cardio-Thoracique, Centre hospitalier universitaire de\nReims\n[10] Rey G, Jougla E, Fouillet A, Hemon D. Ecological associa -\ntion between a deprivation index and mortality in France over\nthe period 1997-2001: Variations with spatial scale, degree\nof urbanicity, age, gender and cause of death. BMC Public\nHealth. 2009;9:33.\n[11] Bush K, Kivlahan DR, McDonell MB, Fihn SD,\nBradley KA. The AUDIT alcohol consumption questions\n(AUDIT-C): An effective brief screening test for problem\ndrinking. Ambulatory Care Quality Improvement Project\n(ACQUIP). Alcohol Use Disorders Identification Test. Arch\nIntern Med. 1998;158(16):1789-95.\n[12] Fuentes S, Mandereau-Bruno L, Regnault N, Bernillon P,\nBonaldi C, Cosson E, et al. Is the type 2 diabetes epidemic\nplateauing in France? A nationwide population-based study.\nDiabetes Metab. 2020;46(6):472-9.\n[13] Mandereau-Bruno L, Fagot-Campagna A, Rey G,\nPiffaretti C, Antero-Jacquemin J, Latouche A, et al.", "mimetype": "text/plain", "start_char_idx": 1865, "end_char_idx": 4157, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ec558eee-5f8a-4269-a304-2b93d23268ce": {"__data__": {"id_": "ec558eee-5f8a-4269-a304-2b93d23268ce", "embedding": null, "metadata": {"page_label": "392", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a3ae29db-75c0-4746-a6a7-ca7082669b01", "node_type": "4", "metadata": {"page_label": "392", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "95742f1bfe203c67154af278904dab9b584815141333fcbff2e5d606ca9d97fd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cd6991e9-3d22-4b82-a0c8-b02abff188ee", "node_type": "1", "metadata": {"page_label": "392", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "884e1c52749d6aca085dcf4e41d690f3a21143f5965de2287e8a821a6c7872ab", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Is the type 2 diabetes epidemic\nplateauing in France? A nationwide population-based study.\nDiabetes Metab. 2020;46(6):472-9.\n[13] Mandereau-Bruno L, Fagot-Campagna A, Rey G,\nPiffaretti C, Antero-Jacquemin J, Latouche A, et al. \u00c9volution de\nla mortalit\u00e9 et de la surmortalit\u00e9 \u00e0 5 ans des personnes diab\u00e9 -\ntiques trait\u00e9es pharmacologiquement en France m\u00e9tropoli -\ntaine : comparaison des cohortes Entred 2001 et Entred 2007.\nBull \u00c9pidemiol Hebd. 2016(37-38):668-75.\nbliquefrance.fr/beh/2016/37-38/2016_37-38_1.html\nCiter cet article\nFosse-Edorh S, Piffaretti C, Saboni L, Mandereau-Bruno L,\nB\u00e9n\u00e9zet L, Raimond V, et al. \u00c9tudes Entred : un dispositif pour\nam\u00e9liorer la connaissance de l'\u00e9tat de sant\u00e9 des personnes\npr\u00e9sentant un diab\u00e8te en France - Premiers r\u00e9sultats de\nla troisi\u00e8me \u00e9dition conduite en m\u00e9tropole en 2019. Bull\nEpid\u00e9miol Hebd. 2022;(22): 383-92.\nfrance.fr/beh/2022/22/2022_22_1.html", "mimetype": "text/plain", "start_char_idx": 3931, "end_char_idx": 4828, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7d9d58b5-da10-4121-966e-20f202083e24": {"__data__": {"id_": "7d9d58b5-da10-4121-966e-20f202083e24", "embedding": null, "metadata": {"page_label": "393", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "60573379-1a34-4523-ab01-e021c584644e", "node_type": "4", "metadata": {"page_label": "393", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "9bbcc7bc26e230775b1fac88e023c8debe0010dcaff26d5cbd8d95ec9a29d4b2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "47dfda85-518f-428f-9e85-da0d636d3111", "node_type": "1", "metadata": {}, "hash": "cc666995a8c6e6bc039380cc3db18634bd98cd88fc546cd4bac26a59ab121a88", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Journ\u00e9e mondiale du diab\u00e8te, 14 novembre 2022 BEH 22 | 8 novembre 2022 | 393\nles populations. Elle repr\u00e9sente de 10 \u00e0 30% environ\ndes personnes DT1. En France, les donn\u00e9es de l'\u00e9tude\n\u00c9chantillon national t\u00e9moin repr\u00e9sentatif des personnes\ndiab\u00e9tiques (Entred), en cours de r\u00e9\u00e9valuation, montrent\nune pr\u00e9valence de 13% chez les personnes DT2 et 39%\nchez les personnes DT1 3 sachant que la pr\u00e9valence du\ntabagisme dans la population g\u00e9n\u00e9rale est de 24%.\nIl est plus fr\u00e9quent chez les hommes jeunes,\naugmente chez les femmes, et est inversement\ncorr\u00e9l\u00e9 au statut socio\u00e9conomique des patients, avec\nune pr\u00e9valence plus importante chez les patients les\nplus pr\u00e9caires (figure 1) .\nTabagisme, composition corporelle,\ninsulinor\u00e9sistance et insulinos\u00e9cr\u00e9tion 4\nIl existe un lien tr\u00e8s probable entre le tabagisme\net l'accumulation de graisse visc\u00e9rale qui fait le\nlit du syndrome m\u00e9tabolique associant variable -\nment DT2, hypertension art\u00e9rielle, hypertriglyc\u00e9ri -\nd\u00e9mie et baisse du HDL-cholest\u00e9rol survenant dans\nun contexte d'insulinor\u00e9sistance.\nEn effet, si le fumeur a en moyenne un poids inf\u00e9 -\nrieur \u00e0 celui du non-fumeur, il pr\u00e9sente en revanche\nun exc\u00e8s de tissu adipeux abdominal avec un\nrapport taille/ hanche plus \u00e9lev\u00e9 qui s'ass ocie \u00e0 une\nd\u00e9gradation de la tol\u00e9rance au glucose et des index\nd'insulinosensibilit\u00e9 5.\nSes m\u00e9canismes sont discut\u00e9s, mais font intervenir\ndes effets :\n\u2022 li\u00e9s \u00e0 la nicotine (principalement \u00e9tudi\u00e9e) : stimulation de la production d'hormones de contrer\u00e9gulation glyc\u00e9miques (cat\u00e9cholamines,\ncortisol, hormone de croissance), effet anti\u0153strog\u00e8nes (figure 2) ;\n\u2022 pro-inflammatoires de la fum\u00e9e de tabac indui -\nsant une inflammation de bas grade ;\n\u2022 de dysfonction endoth\u00e9liale li\u00e9e au stress\noxydatif et cons \u00e9quences de l'hypoxie caus\u00e9e\npar le monoxyde de carbone (CO).\nUn r\u00f4le possible des m\u00e9taux lourds contenus dans la\nfum\u00e9e de cigarette (arsenic, plus que plomb, mercure\nou cadmium) a \u00e9galement \u00e9t\u00e9 \u00e9voqu\u00e9, sachant que la\nfum\u00e9e de tabac contient de l'ordre de 4 700 substances.\nCette insulinor\u00e9sistance est favoris\u00e9e par le taba -\ngisme actif (+ 40 %) mais \u00e9galement par le tabagisme\npassif (+ 28 % ). Des facteurs g\u00e9n\u00e9tiques de pr\u00e9dis -\nposition touchant en particulier le r\u00e9cepteur cholinergique \u00e0 la nicotine pourraient \u00e9galement intervenir.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2280, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "47dfda85-518f-428f-9e85-da0d636d3111": {"__data__": {"id_": "47dfda85-518f-428f-9e85-da0d636d3111", "embedding": null, "metadata": {"page_label": "393", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "60573379-1a34-4523-ab01-e021c584644e", "node_type": "4", "metadata": {"page_label": "393", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "9bbcc7bc26e230775b1fac88e023c8debe0010dcaff26d5cbd8d95ec9a29d4b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7d9d58b5-da10-4121-966e-20f202083e24", "node_type": "1", "metadata": {"page_label": "393", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "e45c5168b7018313d3bf6238bf7317d6f0a99fb59962f88e1a0f65bf63e371bb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Cette insulinor\u00e9sistance est favoris\u00e9e par le taba -\ngisme actif (+ 40 %) mais \u00e9galement par le tabagisme\npassif (+ 28 % ). Des facteurs g\u00e9n\u00e9tiques de pr\u00e9dis -\nposition touchant en particulier le r\u00e9cepteur cholinergique \u00e0 la nicotine pourraient \u00e9galement intervenir.\nL'insulinor\u00e9sistance est r\u00e9versible lors de l'arr \u00eat du\ntabagisme 6.\nM\u00e9canismes mol\u00e9culaires\n\u2022 diminution de l'exp ression de PPAR gamma,\naugmentation de la phosporylation du r\u00e9cep -\nteur de l'ins uline (qui diminue l'ins ulinosen -\nsibilit\u00e9), augmentation de la lipolyse du tissu\nadipeux et de la s\u00e9cr\u00e9tion des Very Low-Density\nLipoprotein (VLDL) (lipoprot\u00e9ines de tr\u00e8s basse\ndensit\u00e9) h\u00e9patiques ;\n\u2022 activation de la sous-unit\u00e9 alpha-7 du r\u00e9cepteur\ncholinergique \u00e0 la nicotine ;\n\u2022 anomalies \u00e9pig\u00e9n\u00e9tiques par m\u00e9thylation aber -\nrante du DNA de g\u00e8nes impliqu\u00e9s dans le risque\nde DT2.\nFigure 1\n\u00c9pid\u00e9miologie du tabagisme de la population diab\u00e9tique mondiale\nAdapt\u00e9 de 3.\nPr\u00e9valence mondiale du tabagisme\nDT2=20,8%\nDT1=10 \u00e0 30%\nFacteurs associ\u00e9s\nau comportement tabagique\nSexe masculin\n\u00c2ge jeune\nS\u00e9dentarit\u00e9\nBas niveau socio\u00e9conomique\nDT2 : 13%\nDT1 : 39%\nEn France", "mimetype": "text/plain", "start_char_idx": 2014, "end_char_idx": 3143, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "30c08b43-7bac-43c6-b771-3f6df187b7a9": {"__data__": {"id_": "30c08b43-7bac-43c6-b771-3f6df187b7a9", "embedding": null, "metadata": {"page_label": "394", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "354c1106-7dbf-4373-be87-68eddaacffb3", "node_type": "4", "metadata": {"page_label": "394", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "29d84caa04647b169ffaa188fe9f2a7f9dc5d4dd18c56a23097b6bb88cddea5a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "deca32bb-429b-43b2-9276-0511e9c52539", "node_type": "1", "metadata": {}, "hash": "fc1ac798b26266f7ade2d9b999712aad260bcf4cbfef33b0e1036d875a326cf5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "394 | 8 novembre 2022 | BEH 22 Journ\u00e9e mondiale du diab\u00e8te, 14 novembre 2022\nEn ce qui conc erne l'insulinosensibilit\u00e9 : des r\u00e9cep -\nteurs nicotiniques ont \u00e9t\u00e9 identifi\u00e9s au niveau des\nterminaisons pr\u00e9-synaptiques sympathiques des\n\u00eelots b\u00eata-pancr\u00e9atiques et des r\u00e9cepteurs postsynaptiques. Le tabagisme est associ\u00e9 \u00e0 une diminution de la fonction b\u00eata-cellulaire mais les potentiels\nm\u00e9canismes, m\u00e9di\u00e9s par la nicotine qui augmenterait\nl'apoptose des cellules b\u00eata, restent insuffisamment\ndocument\u00e9s.\nTabagisme et DT2\nLes donn\u00e9es de nombreuses \u00e9tudes d'obs ervation\nsugg\u00e8rent que le risque relatif de pr\u00e9diab\u00e8te et de\nDT2 est augment\u00e9 de 37 \u00e0 44% chez les fumeurs\npar rapport aux non-fumeurs dans diff\u00e9rentes popu -\nlations (caucasiennes, asiatiques...) 7,8. Ce risque\naugmente de mani\u00e8re dose-d\u00e9pendante 7 et a \u00e9t\u00e9\nconfirm\u00e9 par plusieurs m\u00e9ta-analyses r\u00e9centes 9 sur\ndes donn\u00e9es prospectives ; \u00e0 l'opp os\u00e9 ce risque\ndiminue avec l'arr \u00eat de cons ommation de tabac,\nnotamment apr\u00e8s 10 ans de sevrage. De mani\u00e8re\nint\u00e9ressante le risque de DT2 semble plus marqu\u00e9\nchez les hommes que chez les femmes fumeuses\ndans certaines cohortes, sans explications claires \u00e0\nce ph\u00e9nom\u00e8ne. Le tabac appara\u00eet donc comme un\nfacteur de risque ind\u00e9pendant et modifiable de DT2\ndans la population g\u00e9n\u00e9rale 3.\nNotons \u00e9galement un surcro\u00eet de risque de DT2\nli\u00e9 pour 68% \u00e0 la prise de poids lors du sevrage\ntabagique chez le non-diab\u00e9tique ; celui-ci est\nd'autant plus marqu\u00e9 5 \u00e0 7 ans apr\u00e8s le sevrage,\nest proportionnel \u00e0 l'imp ortance de la prise\nde poids, et d\u00e9cro\u00eet progressivement dans le temps\npour rejoindre un risque \u00e9quivalent \u00e0 celui du nonfumeur uniquement apr\u00e8s 30 ans de sevrage 10.\nTabagisme, mortalit\u00e9 et complications\ndu diab\u00e8te\nChez le DT2, comme chez le DT1 le tabagisme actif\nconstitue le principal facteur de risque de morta -\nlit\u00e9 toutes causes avant m\u00eame l'\u00e9qu ilibre glyc\u00e9 -\nmique, lipidique ou tensionnel 11. Le b\u00e9n\u00e9fice du\nsevrage sur ce risque de mortalit\u00e9 toutes causes\nest d'autant plus important que le sevrage aura \u00e9t\u00e9\npr\u00e9coce.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2033, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "deca32bb-429b-43b2-9276-0511e9c52539": {"__data__": {"id_": "deca32bb-429b-43b2-9276-0511e9c52539", "embedding": null, "metadata": {"page_label": "394", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "354c1106-7dbf-4373-be87-68eddaacffb3", "node_type": "4", "metadata": {"page_label": "394", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "29d84caa04647b169ffaa188fe9f2a7f9dc5d4dd18c56a23097b6bb88cddea5a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "30c08b43-7bac-43c6-b771-3f6df187b7a9", "node_type": "1", "metadata": {"page_label": "394", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "e0153f67a87fb7f5ea01557e79e1a056ea5f36f9bcada2cd83e2b98c4b19f409", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Le b\u00e9n\u00e9fice du\nsevrage sur ce risque de mortalit\u00e9 toutes causes\nest d'autant plus important que le sevrage aura \u00e9t\u00e9\npr\u00e9coce.\nChez le patient DT1 et DT2 le tabagisme actif est\n\u00e9galement un facteur de risque des comp lications macro-angiopathiques du diab\u00e8te (infarctus\ndu myocarde, accident vasculaire c\u00e9r\u00e9bral (AVC),\nart\u00e9riopathie des membres inf\u00e9rieurs), et le risque\naugmente de mani\u00e8re dose-d\u00e9pendante ( figure 3).\nChez le patient DT2, une m\u00e9ta-analyse a montr\u00e9\nque les risques de mortalit\u00e9 cardiovasculaire, de\nmorbidit\u00e9 cardiovasculaire et de coronaropathie\nFigure 2\nM\u00e9canismes impliqu\u00e9s dans l'association entre tabac et diab\u00e8te\nGH : growth hormone (hormone de croissance) ; AGL : acides gras libres ; P : phosphorylation ; IRS1 : Insulin Receptor Substrate 1 (substrat 1 du r\u00e9cepteur\nde l'insuline) ; VLDL : Very Low-Density Lipoprotein (lipoprot\u00e9ine de tr\u00e8s basse densit\u00e9).\nAdapt\u00e9 de 3.\nhormones\nde contre-r\u00e9gulation\nR\u00e9cepteur b\u00eata-3\nR\u00e9cepteur\ncholinergique\nIRS1\n\u0152strog\u00e8nes\nAndrog\u00e8nes\nNicotine\nGH\nCortisol\nCat\u00e9cholamines\nCat\u00e9cholamines\nAGLAGL\nAGLAGL\nAGL\nAGL\nApoptose\nb\u00eata-cellulaire\ns\u00e9cr\u00e9tion VLDL lipolyse\ninsulinor\u00e9sistance insulinos\u00e9cr\u00e9tion\nadiposit\u00e9\nvisc\u00e9rale\ncaptation\ndu glucose fonction b\u00eata-cellulaire", "mimetype": "text/plain", "start_char_idx": 1909, "end_char_idx": 3126, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e312f406-4c13-4881-a21f-da9ae85969cf": {"__data__": {"id_": "e312f406-4c13-4881-a21f-da9ae85969cf", "embedding": null, "metadata": {"page_label": "395", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b96f75af-c04a-45ac-ab4f-9cefa0c0858f", "node_type": "4", "metadata": {"page_label": "395", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "6aac7cb8feaec2eee0b363b315e5f70e7122bcffba847e4e4c56b5a9adc3455d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "81e87b34-7d24-4ac7-9176-bcd47aef2c6d", "node_type": "1", "metadata": {}, "hash": "4dd92ee882ea6b9c5f42c6ac2097545e7e9d163d2e72b6c915be1bf1ee0f89bd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Journ\u00e9e mondiale du diab\u00e8te, 14 novembre 2022 BEH 22 | 8 novembre 2022 | 395\n\u00e9taient de 1,49 (intervalle de confi ance \u00e0 95% :\nIC95%: [1,29-1,71]), 1,44 [1,34-1,54] et 1,51 [1,41-1,62],\nrespectivement. Une relation dose- d\u00e9pendante a\n\u00e9galement \u00e9t\u00e9 \u00e9tablie dans une \u00e9tude prospective\nr\u00e9alis\u00e9e chez des infirmi\u00e8res diab\u00e9tiques (Nurse's\nHealth Study) et dans une \u00e9tude chinoise r\u00e9cente.\nOn retrouve donc une association positive et dosed\u00e9pendante entre le tabagisme et le risque corona -\nrien chez les patients DT2. Dans la m\u00e9ta-analyse de\nPan et coll., les risques de survenue d'AVC et d'art\u00e9riopathie p\u00e9riph\u00e9rique \u00e9taient de 1,54 [1,41 -1,69],\net 2,15 [1,62-2,85] chez les patients fumeurs 3.\nEn ce qui conc erne la micro-angiopathie (n\u00e9phropa -\nthie, r\u00e9tinopathie, neuropathie) le r\u00f4le du tabagisme\ncomme facteur de risque potentiel de r\u00e9tinopathie\ndiab\u00e9tique est \u00e9tabli chez les patients atteints de\nDT1, mais discut\u00e9 chez les patients atteints de DT2 .\nIl est conn u un comme un facteur de risque de la\nn\u00e9phropathie diab\u00e9tique chez le DT2. Il existe enfin\nune association positive entre tabagisme et neuropathie diab\u00e9tique prouv\u00e9e dans le DT1, mais discut\u00e9e\ndans le DT2 12. Dans une m\u00e9ta-analyse r\u00e9cente\nportant sur 82 \u00e9tudes, le risque de r\u00e9tinopathie diab\u00e9tique \u00e9tait augment\u00e9 chez les fumeurs DT1 (risque\nrelatif : RR=1,23 ; IC95%: [1,14-1,33], p < 0,001), mais\ndiminu\u00e9 chez les fumeurs DT2 (RR=0,92 ; IC 95%:\n[0,86-0,98], p=0,02). Chez le diab\u00e9tique de type 2,\ndans une m\u00e9ta-analyse r\u00e9cente portant sur 13 \u00e9tudes\ntransversales ou prospectives, le risque de microal -\nbuminurie \u00e9tait augment\u00e9 chez les patients fumeurs\n(odds ratio : OR=2,13 (IC95%: [1,32-3,45]; p=0002) et\nil existait ainsi une relation lin\u00e9aire entre le tabagisme\net la dur\u00e9e du DT2 avec l'albuminurie 3.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1777, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "81e87b34-7d24-4ac7-9176-bcd47aef2c6d": {"__data__": {"id_": "81e87b34-7d24-4ac7-9176-bcd47aef2c6d", "embedding": null, "metadata": {"page_label": "395", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b96f75af-c04a-45ac-ab4f-9cefa0c0858f", "node_type": "4", "metadata": {"page_label": "395", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "6aac7cb8feaec2eee0b363b315e5f70e7122bcffba847e4e4c56b5a9adc3455d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e312f406-4c13-4881-a21f-da9ae85969cf", "node_type": "1", "metadata": {"page_label": "395", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "04eb68f12aefd808a2f810143cb214c2e20fae36f8387374858735c36330a7ac", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3136e20c-72c4-4e3a-a25f-1e01bfbd7258", "node_type": "1", "metadata": {}, "hash": "3aba4860fc2836175b17065c409ce65af4a9115e94a37b57ce877a2660bdf30f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Les m\u00e9canismes impliqu\u00e9s dans l'aggravation des\ncomplications micro- et macro-angiopathiques sont\ncomplexes et intriqu\u00e9s : li\u00e9s \u00e0 l'ins ulinor\u00e9sistance\n(hypertriglyc\u00e9rid\u00e9mie, diminution du HDL-cholest\u00e9rol,\nperoxydation des LDL...), ainsi qu'\u00e0 la dysfonction\nendoth\u00e9liale associant spasme et thrombose favo -\nris\u00e9e par l'hypoxie (CO-d\u00e9pendante) et \u00e0 l'infl ammation de la paroi art\u00e9rielle.\nAutres complications 3\nLa consommation de tabac chez les sujets diab\u00e9tiques\n(la majorit\u00e9 des donn\u00e9es concernant les DT2) est associ\u00e9e \u00e0 un surrisque de survenue de cancer avec un\nrisque relatif fumeur/non-fumeur de l'ordre de 1,6 ; elle\nFigure 3\nComplications du tabagisme dans la population diab\u00e9tique\nIDM : infarctus du myocarde ; AVC: accident vasculaire c\u00e9r\u00e9bral ; LDL : Low-Density lipoprotein ; TG: triglyc\u00e9rides ; HDL : High-Density lipoprotein ;\nDT1: diab\u00e8te de type 1 ; DT2 : diab\u00e8te de type 2 ; CHC : carcinome h\u00e9pato-cellulaire ; HbA1c (h\u00e9moglobine glyqu\u00e9e).\nAdapt\u00e9 de 3.", "mimetype": "text/plain", "start_char_idx": 1778, "end_char_idx": 2749, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3136e20c-72c4-4e3a-a25f-1e01bfbd7258": {"__data__": {"id_": "3136e20c-72c4-4e3a-a25f-1e01bfbd7258", "embedding": null, "metadata": {"page_label": "395", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b96f75af-c04a-45ac-ab4f-9cefa0c0858f", "node_type": "4", "metadata": {"page_label": "395", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "6aac7cb8feaec2eee0b363b315e5f70e7122bcffba847e4e4c56b5a9adc3455d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "81e87b34-7d24-4ac7-9176-bcd47aef2c6d", "node_type": "1", "metadata": {"page_label": "395", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "8c2b443cf08c34a5998b593f0410b5a0171347f048b446e2e932a3cbcef9e4d0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Adapt\u00e9 de 3.\nContr\u00f4le glyc\u00e9mique\nComplications macrovasculaires\nInfections\nCancer\nComplications microvasculaires\n\nAutres complications\nComplications obst\u00e9tricales\nChez la femme enceinte diab\u00e9tique\nen pr\u00e9-conceptionnel, pr\u00e9dicteur de :\nD\u00e9pression\nDans le DT1, manque de donn\u00e9es\ndes \u00e9pisodes majeurs et mineurs de d\u00e9pression\ndans le DT2\ndes \u00e9v\u00e9nements cardiovasculaires\n(maladie coronarienne, IDM et AVC)\nmortalit\u00e9 cardiovasculaire\nDyslipid\u00e9mie ( LDL, TG, HDL)\nMauvais contr\u00f4le glyc\u00e9mique\n(HbA1c \u00e9lev\u00e9e)\nDans le DT1 :\nrisque hypoglyc\u00e9mique\nvariabilit\u00e9 glyc\u00e9mique\ndu risque d'hospitalisation\npour infection respiratoire, urinaire\nou cutan\u00e9e\nFacteur de risque de tuberculose\nnotamment de formes s\u00e9v\u00e8res\nDans le DT2 :\nDans le DT1, manque de donn\u00e9es\nd'au moins 60% du risque de cancer\ntoutes causes\ncancer du pancr\u00e9as\nCHC (carcinome h\u00e9patocellulaire\ncancer colorectal\nDans le DT1 :\nDans le DT2 :\nn\u00e9phropathie diab\u00e9tique\nr\u00e9tinopathie diab\u00e9tique\nneuropathie diab\u00e9tique\nn\u00e9phropathie diab\u00e9tique\n(moins clairement \u00e9tabli)\nr\u00e9tinopathie diab\u00e9tique\nneuropathie diab\u00e9tique\n(moins clairement \u00e9tabli)\nAugmentation du risque\nde parodontite\nAcc\u00e9l\u00e9ration de la perte de masse\nosseuse et augmentaton du risque\nfracturaire chez la femme m\u00e9nopaus\u00e9e\nmortalit\u00e9 p\u00e9rinatale\nmalformations cong\u00e9nitales", "mimetype": "text/plain", "start_char_idx": 2737, "end_char_idx": 4010, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4320e6dd-9139-4331-b0cc-f1828897074f": {"__data__": {"id_": "4320e6dd-9139-4331-b0cc-f1828897074f", "embedding": null, "metadata": {"page_label": "396", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b4f2d521-a3a4-4e5b-bb4e-c3cf00f268e8", "node_type": "4", "metadata": {"page_label": "396", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "1e3e47ed1467e935a21f4949ddc132420479a6f0f829ade5262bf8c8db87f318", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f36052f6-5b03-4731-9e8a-d1a2e4dccf93", "node_type": "1", "metadata": {}, "hash": "40d393e39bafe0d685916bb4288517b3d2f7fa24c97ce986024acbf89207e09d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "396 | 8 novembre 2022 | BEH 22 Journ\u00e9e mondiale du diab\u00e8te, 14 novembre 2022\nest \u00e9galement li\u00e9e \u00e0 un exc\u00e8s de mortalit\u00e9 par cancer\navec un risque relatif fumeur/non-fumeur de l'ordre de\n1,4, et cet exc\u00e8s d\u00e9cro\u00eet avec le sevrage tabagique.\nLes sujets diab\u00e9tiques fumeurs actuels ont \u00e9galement\nun risque plus \u00e9lev\u00e9 d'hos pitalisation pour infection\npar rapport aux sujets diab\u00e9tiques non-fumeurs, et\nce avec un risque relatif de l'ordre de 1,3.\nLe tabagisme est associ\u00e9 \u00e0 un risque d'amp utation\nplus \u00e9lev\u00e9 chez les patients diab\u00e9tiques avec un pied\ninfect\u00e9.\nLa consommation du tabac chez les sujets diab\u00e9 -\ntiques est associ\u00e9e \u00e0 un risque accru de survenue et\nde progression de parodontopathies.\nTabagisme, diab\u00e8te, et d\u00e9pression 13,14\nLe DT2, plus volontiers d\u00e9pressif que le nondiab\u00e9tique, l'est d'autant plus qu'il fume plus de\n11 cigarettes/jour. Il existe une relation positive\nentre le nombre de cigarettes fum\u00e9es et la s\u00e9v\u00e9 -\nrit\u00e9 du syndrome d\u00e9pressif ; de plus, le tabagisme\ns'associe \u00e0 une d\u00e9gradation de la qualit\u00e9 de vie du\npatient diab\u00e9tique ainsi qu'a une augmentation des\ncomorbidit\u00e9s. La fr\u00e9quente pr\u00e9sence d'un syndrome\nd\u00e9pressif chez le diab\u00e9tique rend le sevrage d'autant\nplus difficile \u00e0 appr\u00e9hender.\nLe tabagisme appara\u00eet donc comme un facteur\nde risque ind\u00e9pendant de d\u00e9pression chez le\npatient DT2, et la pr\u00e9vention du tabagisme doit \u00eatre\nconsid\u00e9r\u00e9e afin de limiter le risque de d\u00e9veloppement\nd'une symptomatologie d\u00e9pressive.\nChez le patient DT1, les donn\u00e9es sont limit\u00e9es et ne\npermettent pas de conclure.\nTabagisme, diab\u00e8te et femme\nLe tabagisme pendant la grossesse est associ\u00e9\n\u00e0 une augmentation du risque de diab\u00e8te gesta -\ntionnel (DG) chez la femme fumeuse (OR=1,65), puis\nde diab\u00e8te patent ; \u00e0 l'opp os\u00e9, l'absence de taba -\ngisme et le sevrage du tabac (associ\u00e9e aux r\u00e8gles\nhygi\u00e9no- di\u00e9t\u00e9tiques) diminuent le risque de diab\u00e8te\ngestationnel.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1872, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f36052f6-5b03-4731-9e8a-d1a2e4dccf93": {"__data__": {"id_": "f36052f6-5b03-4731-9e8a-d1a2e4dccf93", "embedding": null, "metadata": {"page_label": "396", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b4f2d521-a3a4-4e5b-bb4e-c3cf00f268e8", "node_type": "4", "metadata": {"page_label": "396", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "1e3e47ed1467e935a21f4949ddc132420479a6f0f829ade5262bf8c8db87f318", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4320e6dd-9139-4331-b0cc-f1828897074f", "node_type": "1", "metadata": {"page_label": "396", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "19c16ddde20f11c7fd6d05af1e7425c292a4ee44f1e819999e99e6c70b3d4992", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dd5efec8-e471-400b-af2b-e3f016f5f02b", "node_type": "1", "metadata": {}, "hash": "d5a42d9c96f409f1e2481b94c7bbd13fc37aceab7c056787f51eb41ff89bc44a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Le tabagisme maternel majore le risque de retard de\ncroissance intra-ut\u00e9rin, de fausse couche pr\u00e9coce,\nde grossesse extra-ut\u00e9rine, d'ano malie cong\u00e9nitale,\nd'h\u00e9matome r\u00e9troplacentaire, de placenta pr\u00e6via,\nde pr\u00e9maturit\u00e9, de mort f\u0153tale in utero , de c\u00e9sa -\nrienne, de petit poids de naissance lui-m\u00eame facteur\nde risque de surpoids, d'ob\u00e9 sit\u00e9 abdominale et de\nDT2 pour l'enfant probablement par des m\u00e9canismes\n\u00e9pig\u00e9n\u00e9tiques 15.\nDans un contexte de diab\u00e8te gestationnel chez les\nfemmes fumeuses, l'\u00e9qu ilibre glyc\u00e9mique appa -\nra\u00eet globalement moins bon avec une plus grande\nfr\u00e9quence d'instauration d'une insulinoth\u00e9rapie.\nDe plus les enfants de femmes fumeuses ont un\nrisque de DT2 augment\u00e9 de 34% en cas de taba -\ngisme actif et de 22% en cas de tabagisme passif.\nL 'association tabagisme, ob\u00e9sit\u00e9 et DT2 est par\nailleurs responsable de l'aug mentation pr\u00e9occu -\npante de l'incidence de la maladie coronarienne chez\nla femme 16.\nDans le DT1, nous manquons de donn\u00e9es.\nTabagisme et \u00e9quilibre glyc\u00e9mique 3\nL 'HbA1c (h\u00e9moglobine glyqu\u00e9e) est plus \u00e9lev\u00e9 chez\nles fumeurs actifs (+ 0,12% par 20 paquets/ann\u00e9e)\nnon DT2 et les ex-fumeurs (+ 0,03 %) que chez les\nnon-fumeurs. L 'augmentation d'HbA1c observ\u00e9e\nest corr\u00e9l\u00e9e \u00e0 celle de la cotinine urinaire (catabo -\nlite de la nicotine). Chez les patients DT1, DT2 et les\npatientes porteuses d'un DG, le tabagisme actif est\nassoci\u00e9 \u00e0 une d\u00e9t\u00e9rioration de l'\u00e9quilibre glyc\u00e9mique\navec une relation dose-d\u00e9pendante en fonction de\nla s\u00e9v\u00e9rit\u00e9 du tabagisme.\nLorsque le diab\u00e9tique est trait\u00e9 et qu'il est fumeur son\n\u00e9quilibre glyc\u00e9mique est de moins bonne qualit\u00e9 ;\ns'il est trait\u00e9 par l'ins uline, une r\u00e9sorption retard\u00e9e\nde l'insuline pourrait participer \u00e0 un \u00e9quilibre glyc\u00e9 -\nmique plus instable ; l'instabilit\u00e9 glyc\u00e9mique est plus\nfr\u00e9quente en particulier chez le DT1, le risque d'hypoglyc\u00e9mies s\u00e9v\u00e8res est augment\u00e9.", "mimetype": "text/plain", "start_char_idx": 1873, "end_char_idx": 3731, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dd5efec8-e471-400b-af2b-e3f016f5f02b": {"__data__": {"id_": "dd5efec8-e471-400b-af2b-e3f016f5f02b", "embedding": null, "metadata": {"page_label": "396", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b4f2d521-a3a4-4e5b-bb4e-c3cf00f268e8", "node_type": "4", "metadata": {"page_label": "396", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "1e3e47ed1467e935a21f4949ddc132420479a6f0f829ade5262bf8c8db87f318", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f36052f6-5b03-4731-9e8a-d1a2e4dccf93", "node_type": "1", "metadata": {"page_label": "396", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "3f627f15e99af00997aff2ef80d1d5f596355a0eac4a7bbaac0063d0704c6ef4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "L 'ensemble de ces \u00e9l\u00e9ments souligne donc :\n\u2022 l'int\u00e9r\u00eat de ne pas devenir fumeur lorsque\nl'on est \u00e0 risque de diab\u00e8te afin de pr\u00e9venir la\nsurvenue d'un diab\u00e8te gestationnel ou d'un\ndiab\u00e8te patent ;\n\u2022 la n\u00e9cessit\u00e9 du sevrage tabagique chez les\npatients DT1 et DT2 fumeurs pour diminuer la\nmortalit\u00e9 toutes causes et/ou cardiovasculaire,\net pour r\u00e9duire et/ ou limiter les comp lications\nmicro-angiopathiques (tableau).\nSevrage tabagique chez le diab\u00e9tique 3\nLes recommandations actuelles (European Society\nof Cardiology (ESC) - European Association For\nthe Study of Diabetes (EASD)) soulignent l'int \u00e9r\u00eat et\nla n\u00e9cessit\u00e9 du sevrage tabagique chez les sujets\npr\u00e9diab\u00e9tiques ou diab\u00e9tiques 17, m\u00eame si cette\nmesure th\u00e9rapeutique essentielle n'est pas suffisamment prise en consid\u00e9ration par les professionnels de\nsant\u00e9 en diab\u00e9tologie.\nIl ne fait cependant l'objet que de peu d'\u00e9tudes reposant sur des interventions psycho- comportementales\n(intervention br\u00e8ve, entretien motivationnel (EM),\nsoutien t\u00e9l\u00e9phonique, autosupport num\u00e9rique, acti -\nvit\u00e9 physique, \u00e9ventuellement int\u00e9gr\u00e9s dans des\nprogrammes d'\u00e9ducation th\u00e9rapeutique) associ\u00e9es\nou non \u00e0 une intervention pharmacologique (substi -\ntution nicotinique (SN), utilisation de bupropion ou de\nvar\u00e9nicline) 18.\nAinsi l'EM montre un b\u00e9n\u00e9fice, avec 1,4 \u00e0 7 fois\nplus de sevrage du tabac chez les patients DT1\net DT2. Soulignons que 85% des \u00e9tudes ayant\nmontr\u00e9 un b\u00e9n\u00e9fice de l'EM, proposent des aides", "mimetype": "text/plain", "start_char_idx": 3732, "end_char_idx": 5181, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6dcb3980-07d8-480d-bdd4-4ba736e63eac": {"__data__": {"id_": "6dcb3980-07d8-480d-bdd4-4ba736e63eac", "embedding": null, "metadata": {"page_label": "397", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e370fa72-1940-452f-b541-be9a1d27bbff", "node_type": "4", "metadata": {"page_label": "397", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "a97f0bc647a8e4715933d69f272a1a861de041bcb5a5681eead04626d306ebee", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7e2283e8-1552-47ec-aedb-d926e1b5c24b", "node_type": "1", "metadata": {}, "hash": "d9cb2723d0ac83caf4df702fcd66fc0cc82caf2df6d02b44dd8f1c59969324ec", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Journ\u00e9e mondiale du diab\u00e8te, 14 novembre 2022 BEH 22 | 8 novembre 2022 | 397\npharmacologiques dans le groupe intervention, ce\nqui ne permet pas de juger de l'efficacit\u00e9 de l'EM seul\ndans le sevrage tabagique.\nL '\u00e9tude de Canga et coll. 19 montre dans un groupe\nde 280 DT2 qu'une intervention d'aid e au sevrage\npratiqu\u00e9e par une infirmi\u00e8re tabacologue associant\nentretien, SN si n\u00e9cessaire et suivi personnalis\u00e9\npermet une r\u00e9duction significative de la cons ommation tabagique \u00e0 6 mois, et ce par rapport aux\nsoins habituels de simples cons eils d'arr\u00eat (17,0%\nvs 2,3%, p<0,001). Des \u00e9tudes d'int ervention th\u00e9ra -\npeutique portant sur des effectifs plus larges de\npatients diab\u00e9tiques sont donc ici n\u00e9cessaire s,\nen l'absence de donn\u00e9es sp\u00e9cifiques et de qualit\u00e9\nsuffisante sur l'efficacit\u00e9 et la tol\u00e9rance chez les\npatients DT1 et DT2. Il existe un accord des sp\u00e9cia -\nlistes pour consid\u00e9rer la transposition des r\u00e9sultats\ndes \u00e9valuations venant de la population g\u00e9n\u00e9rale\nnon- diab\u00e9tique fumeuse vers celle des diab\u00e9tiques\nfumeurs ( tableau).\nChez les patients diab\u00e9tiques, l'arr\u00eat du tabac doit\n\u00eatre associ\u00e9 \u00e0 des mesures hygi\u00e9no-di\u00e9t\u00e9tiques\nrenforc\u00e9es, notamment dans les premi\u00e8res ann\u00e9es\nsuivant l'arr\u00eat. Aucune donn\u00e9e \u00e0 ce jour ne permet\nde re commander la modification du traitement \u00e0\nvis\u00e9e antidiab\u00e9tique pr\u00e9alablement au sevrage.\nDans l'ann\u00e9e suivant le sevrage une surveillance\nrenforc\u00e9e des param\u00e8tres glyc\u00e9miques et du poids\nest n\u00e9cessaire.\nLe sevrage tabagique se heurte par ailleurs comm e\nchez les non-diab\u00e9tiques \u00e0 la question sensible\nde la prise de poids, susceptible de d\u00e9grader\nl'\u00e9quilibre glyc\u00e9mique et cont re laquelle le patient\ndiab\u00e9tique est sensibilis\u00e9 en permanence. Une\nm\u00e9ta- analyse portant sur 62 \u00e9tudes 20 a montr\u00e9\nque celle-ci, bien que fr\u00e9quente (prise de 4 \u00e0 5 kg\napr\u00e8s 12 mois d'abstinence), survient essentielle -\nment dans les six premiers mois suivant le sevrage,\nn'est pas in\u00e9luctable (de 16 \u00e0 21% des sujets\nperdent du poids), ceci quels que soient les trai -\ntements utilis\u00e9s (substitution nicotinique, bupro -\npion, var\u00e9nicline). Elle semble \u00eatre plus importante\nchez les femmes que chez les hommes, mais les\ndonn\u00e9es de la litt\u00e9rature sont limit\u00e9es et parfois\ncontradictoires.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2218, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7e2283e8-1552-47ec-aedb-d926e1b5c24b": {"__data__": {"id_": "7e2283e8-1552-47ec-aedb-d926e1b5c24b", "embedding": null, "metadata": {"page_label": "397", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e370fa72-1940-452f-b541-be9a1d27bbff", "node_type": "4", "metadata": {"page_label": "397", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "a97f0bc647a8e4715933d69f272a1a861de041bcb5a5681eead04626d306ebee", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6dcb3980-07d8-480d-bdd4-4ba736e63eac", "node_type": "1", "metadata": {"page_label": "397", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "5109ff826cd07ffd617852ec4ef0cf3909cc9144ac4ff037e0c6a53fa35be2d8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e1e36274-be71-4771-a500-5becb9943cae", "node_type": "1", "metadata": {}, "hash": "59ec39671e04acbe21e4ab23d61f1eda03d8e4d21cdce145b51fb3ddda907235", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Elle semble \u00eatre plus importante\nchez les femmes que chez les hommes, mais les\ndonn\u00e9es de la litt\u00e9rature sont limit\u00e9es et parfois\ncontradictoires.\nDe plus, le b\u00e9n\u00e9fice du sevrage tabagique essentiel -\nlement \u00e9valu\u00e9 chez le DT2, en particulier sur le plan de\nla mortalit\u00e9 totale et cardiovasculaire est significativement sup\u00e9rieur sur le long terme au r\u00e9el inconv\u00e9nient\nrepr\u00e9sent\u00e9 par la prise de poids et/ ou la d\u00e9gradation\nde l'\u00e9quilibre glyc\u00e9mique chez le diab\u00e9tique.\nConclusion\nLe tabagisme constitue un facteur de risque d\u00e9montr\u00e9\nde pr\u00e9-diab\u00e8te, de DT2 et de DG. Il est associ\u00e9 \u00e0 une\nd\u00e9gradation de l'\u00e9qu ilibre glyc\u00e9mique.", "mimetype": "text/plain", "start_char_idx": 2072, "end_char_idx": 2699, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e1e36274-be71-4771-a500-5becb9943cae": {"__data__": {"id_": "e1e36274-be71-4771-a500-5becb9943cae", "embedding": null, "metadata": {"page_label": "397", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e370fa72-1940-452f-b541-be9a1d27bbff", "node_type": "4", "metadata": {"page_label": "397", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "a97f0bc647a8e4715933d69f272a1a861de041bcb5a5681eead04626d306ebee", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7e2283e8-1552-47ec-aedb-d926e1b5c24b", "node_type": "1", "metadata": {"page_label": "397", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "d1db6eb81ffe40e398358ff40fef9929cc4fca4a36abcf16cbf615bee8808b3b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Conclusion\nLe tabagisme constitue un facteur de risque d\u00e9montr\u00e9\nde pr\u00e9-diab\u00e8te, de DT2 et de DG. Il est associ\u00e9 \u00e0 une\nd\u00e9gradation de l'\u00e9qu ilibre glyc\u00e9mique. Il cons titue\n\u00e9galement la premi\u00e8re cause de mortalit\u00e9 chez les\nTableau\nConsensus de la Soci\u00e9t\u00e9 francophone de tabacologie et de la Soci\u00e9t\u00e9 francophone du diab\u00e8te sur le tabagisme et le diab\u00e8te\nRecommandation Grade Niveau\nde preuve\nLes professionnels de sant\u00e9 devraient en pratique quotidienne informer les patients diab\u00e9tiques sur les risques\ndu tabagisme et leur conseiller de ne pas commencer \u00e0 fumer A 1\nTous les sujets diab\u00e9tiques fumeurs devraient recevoir des conseils d'aide au sevrage tabagique et devraient \u00eatre\ninform\u00e9s des b\u00e9n\u00e9fices du sevrage tabagique A 1\nChez les femmes diab\u00e9tiques le sevrage tabagique devrait \u00eatre propos\u00e9 avant toute grossesse A 2\nIl serait important de promouvoir de nouveaux programmes de pr\u00e9vention et de sevrage tabagique sp\u00e9cifiquement\nadapt\u00e9s aux besoins des femmes diab\u00e9tiques, car leurs modalit\u00e9s d'adaptation et contextes sociaux peuvent \u00eatre\ndiff\u00e9rents de ceux des hommes diab\u00e9tiques\nC 4\nLes d\u00e9marches de sevrage tabagique chez le diab\u00e9tique devraient \u00eatre accompagn\u00e9e d'une surveillance stricte\nde l'\u00e9quilibre glyc\u00e9mique et d'intervention sur le mode de vie, telles que l'augmentation de l'activit\u00e9 physique\net la r\u00e9duction du poids\nA 2\nLa fa\u00e7on la plus efficace de promouvoir le sevrage tabagique serait d'associer des th\u00e9rapeutiques psychocomportementales et pharmacologiques C 3\nLes m\u00e9dicaments de premi\u00e8re ligne dans le sevrage tabagique, substituts nicotiniques, var\u00e9nicline et bupropion\ninclus C 3\nChez les femmes enceintes, les th\u00e9rapeutiques psychocomportementales seules seraient recommand\u00e9es,\nen raison de l'absence de donn\u00e9es document\u00e9es sur la s\u00e9curit\u00e9 des pharmacoth\u00e9rapies pendant la grossesse C 4\nLa pharmacoth\u00e9rapie dans le sevrage tabagique dure au moins 3 mois C 4\nChez les patients utilisant un traitement de substitution nicotinique il est pr\u00e9f\u00e9rable d'associer des produits\nde remplacement nicotinique de longue et de courte dur\u00e9e d'action (timbre nicotinique et formes orales :\npastilles ou gommes)\nC 4\nLa e-cigarette (ou vapoteuse) utilis\u00e9e dans le cadre du sevrage tabagique doit l'\u00eatre un temps limit\u00e9, et arr\u00eat\u00e9e\nd\u00e8s que l'abstinence est obtenue et l'urgence de fumer contr\u00f4l\u00e9e C 4\nLes recommandations ci-dessus utilisent le mod\u00e8le de gradation de la Haute Autorit\u00e9 de sant\u00e9 (HAS).\nD'apr\u00e8s 3.", "mimetype": "text/plain", "start_char_idx": 2542, "end_char_idx": 4964, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "af84de6f-6f8b-44a7-9780-4e917c157c25": {"__data__": {"id_": "af84de6f-6f8b-44a7-9780-4e917c157c25", "embedding": null, "metadata": {"page_label": "398", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "05e4217d-ebb8-4b7f-8e53-31519b6d26b2", "node_type": "4", "metadata": {"page_label": "398", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "ec8256382c2ceee5abcbb5f68bb78f8815ba1f86e3bd12deb24977c28b7e059d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ea059d17-73b0-419d-abbb-121836be50cb", "node_type": "1", "metadata": {}, "hash": "6f82a2fdae3aa21f485ee5850ee4d657f5474579699b88391a9d048206d4cd0d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "398 | 8 novembre 2022 | BEH 22 Journ\u00e9e mondiale du diab\u00e8te, 14 novembre 2022\nDT2 et est un d\u00e9terminant majeur des complications\nmicro-angiopathiques (n\u00e9phropathie) et macroangiopathiques. Il y a donc un b\u00e9n\u00e9fice majeur \u00e0\nd\u00e9courager toute cons ommation tabagique chez\nle patient \u00e0 risque de diab\u00e8te (pr\u00e9vention primaire),\nou \u00e0 l'aid er \u00e0 se sevrer s'il est d\u00e9j\u00e0 diab\u00e9tique et\nfumeur (pr\u00e9vention secondaire). Compte-tenu du peu\nd'\u00e9tudes sur la strat\u00e9gie sp\u00e9cifique de prise en charge\nth\u00e9rapeutique du sevrage tabagique chez les patients\ndiab\u00e9tiques, l'application des m\u00eames principes\nqu'en population g\u00e9n\u00e9rale est donc recommand\u00e9e,\nen combinant des th\u00e9rapeutiques psycho- comportementales et pharmacologiques ( tableau ). Une\nsensibilisation et une formation \u00e0 l'aid e au sevrage\ntabagique des \u00e9quipes \u00e9ducatives diab\u00e9tologiques\nsont par ailleurs indispensables. \u25a0\nRemerciements\nDans le cadre du groupe de travail Tabagisme et diab\u00e8te,\nl'auteur tient \u00e0 remercier St\u00e9phanie Genou-Vannobel et\nIsabelle Gaudy (infirmi\u00e8res tabacologues) pour leurs conseils\npertinents, ainsi que Laura Phirmis et Claude Chaumeil de la\nF\u00e9d\u00e9ration fran\u00e7aise des diab\u00e9tiques (FFD) pour leurs conseils\njudicieux.\nLiens d'int\u00e9r\u00eat\nL 'auteur d\u00e9clare ne pas avoir de liens d'int\u00e9r\u00eat au regard\ndu contenu de l'article. Il d\u00e9clare par ailleurs avoir parti -\ncip\u00e9 \u00e0 des essais cliniques pour les laboratoires Amgen,\nSanofi, Bioprojet, \u00e0 des conf\u00e9rences, colloques ou actions\nde formation pour les laboratoires Amgen, Sanofi et Servier,\nMSD et pour Preuves & Pratiques, et avoir \u00e9t\u00e9 pris en charge\n(transport, h\u00f4tel, repas), \u00e0 l'occasion de d\u00e9placements pour\ncongr\u00e8s, par les laboratoires Servier, Amgen, Sanofi, Novo\nNordisk.\nR\u00e9f\u00e9rences\n[1] T\u00f6nnies T, Rathmann W, Hoyer A, Brinks R, Kuss O.\nQuantifying the underestimation of projected global\ndiabetes prevalence by the International Diabetes Fede -\nration (IDF) Diabetes Atlas. BMJ Open Diabetes Res Care.\n2021;9(1):e002122.\n[2] Roderick P, Turner V, Readshaw A, Dogar O, Siddiqi K. The\nglobal prevalence of tobacco use in type 2 diabetes mellitus\npatients: A systematic review and meta-analysis. Diabetes Res\nClin Pract. 2019;154: 52-65.\n[3] Durlach V, Verg\u00e8s B, Al-Salameh A, Bahougne T,\nBenzerouk F, Berlin I, et al .", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2237, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ea059d17-73b0-419d-abbb-121836be50cb": {"__data__": {"id_": "ea059d17-73b0-419d-abbb-121836be50cb", "embedding": null, "metadata": {"page_label": "398", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "05e4217d-ebb8-4b7f-8e53-31519b6d26b2", "node_type": "4", "metadata": {"page_label": "398", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "ec8256382c2ceee5abcbb5f68bb78f8815ba1f86e3bd12deb24977c28b7e059d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "af84de6f-6f8b-44a7-9780-4e917c157c25", "node_type": "1", "metadata": {"page_label": "398", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "e8dc5a1f72a90641d855bafe2f6c968ceea21b05e3039cc62db324810a40c565", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1a61ebca-408f-485d-8666-d7a2c1f85455", "node_type": "1", "metadata": {}, "hash": "dd8a8a3e6d60badb6c5942062af23ad80dc7a4b1e62b2c2d68e52636aa92c9d3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Diabetes Res\nClin Pract. 2019;154: 52-65.\n[3] Durlach V, Verg\u00e8s B, Al-Salameh A, Bahougne T,\nBenzerouk F, Berlin I, et al . Smoking and diabetes interplay:\nA comprehensive review and joint statement. Diabetes Metab.\n2022;48(6):101370.\n[4] Maddatu J, Anderson-Baucum E, Evans-Molina C. Smoking\nand the risk of type 2 diabetes. Transl Res. 2017;184:101-7.\n[5] Aeschbacher S, Schoen T, Clair C, Schillinger P, Sch\u00f6nen -\nberger, Risch M, et al . Association of smoking and nicotine\ndependence with pre-diabetes in young and healthy adults.\nSwiss Med Wkly. 2014;144:w14019.\n[6] Berlin I. Smoking-induced metabolic disorders: A review.\nDiabetes Metab. 2008;34(4 Pt 1):307-14.\n[7] Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active\nsmoking and the risk of type 2 diabetes: A systematic review\nand meta-analysis. JAMA. 2007;298(22):2654-64.\n[8] U.S. Department of Health and Human Services. The health\nconsequences of smoking - 50 years of progress: A report\nof the Surgeon General. Atlanta: Centers for Disease Control\nand Prevention; 2014.\n[9] Akter S, Goto A, Mizoue T. Smoking and the risk of\ntype 2 diabetes in Japan: A systematic review and metaanalysis. J Epidemiol. 2017;27(12):553-61.\n[10] Hu Y, Zong G, Liu G, Wang M, Rosner B, Pan A, et al .\nSmoking cessation, weight change, type 2 diabetes, and\nmortality. N Engl J Med. 2018;379(7):623-32.\n[11] Rawshani A, Rawshani A, Franz\u00e9n S, Sattar N, Eliasson B,\nSvensson AM, et al. Risk factors, mortality, and cardiovas -\ncular outcomes in patients with type 2 diabetes. N Engl J Med.\n2018;379(7):633-44.\n[12] Pan A, Wang Y, Talaei M, Hu FB, Wu T. Relation of active,\npassive, and quitting smoking with incident type 2 diabetes:\nA systematic review and meta-analysis. Lancet Diabetes\nEndocrinol. 2015;3(12):958-67.\n[13] Haire-Joshu D, Heady S, Thomas L, Schechtman K,\nFisher EB Jr. Depressive symptomatology and smoking among\npersons with diabetes. Res Nurs Health. 1994;17(4):273-82.\n[14] Clyde M, Smith KJ, Gari\u00e9py G, Schmitz N. The association\nbetween smoking and depression in a Canadian communitybased sample with type 2 diabetes. Can J Diabetes.", "mimetype": "text/plain", "start_char_idx": 2114, "end_char_idx": 4219, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1a61ebca-408f-485d-8666-d7a2c1f85455": {"__data__": {"id_": "1a61ebca-408f-485d-8666-d7a2c1f85455", "embedding": null, "metadata": {"page_label": "398", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "05e4217d-ebb8-4b7f-8e53-31519b6d26b2", "node_type": "4", "metadata": {"page_label": "398", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "ec8256382c2ceee5abcbb5f68bb78f8815ba1f86e3bd12deb24977c28b7e059d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ea059d17-73b0-419d-abbb-121836be50cb", "node_type": "1", "metadata": {"page_label": "398", "file_name": "2022_22.pdf", "file_path": "D:\\Documents\\DEV\\dev_ia_simplon\\briefs\\diabete-rag\\documents\\2022_22.pdf", "file_type": "application/pdf", "file_size": 1843017, "creation_date": "2025-11-25", "last_modified_date": "2025-11-25", "cleaned": true, "headlines": []}, "hash": "1b689815e8738aebb31f1b555d0d0959060c66c8ad84eba5c2e8bd19b8368af3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Depressive symptomatology and smoking among\npersons with diabetes. Res Nurs Health. 1994;17(4):273-82.\n[14] Clyde M, Smith KJ, Gari\u00e9py G, Schmitz N. The association\nbetween smoking and depression in a Canadian communitybased sample with type 2 diabetes. Can J Diabetes.\n2013;37(3):150-5.\n[15] Ino T, Shibuya T, Saito K, Inaba Y. Relationship between\nbody mass index of offspring and maternal smoking during\npregnancy. Int J Obes. 2012;36(4):554-8.\n[16] Al-Delaimy WK, Manson JE, Solomon CG, Kawachi I,\nStampfer MJ, Willett WC, et al . Smoking and risk of coronary\nheart disease among women with type 2 diabetes mellitus.\nArch Intern Med. 2002;162(3):273-9.\n[17] Grant PJ, Cosentino F. The 2019 ESC Guidelines on\ndiabetes, pre-diabetes, and cardiovascular diseases deve -\nloped in collaboration with the EASD: New features and the\n'Ten Commandments' of the 2019 Guidelines are discussed by\nProfessor Peter J. Grant and Professor Francesco Cosentino,\nthe Task Force chairmen. Eur Heart J. 2019;40(39):3215-17.\n[18] Nagrebetsky A, Brettell R, Roberts N, Farmer A. Smoking\ncessation in adults with diabetes: A systematic review and\nmeta-analysis of data from randomised controlled trials. BMJ\nOpen. 2014;4(3):e004107.\n[19] Canga N, De Irala J, Vara E, Duaso MJ, Ferrer A, Mart\u00ednezGonz\u00e1lez MA. Intervention study for smoking cessation in\ndiabetic patients: A randomized controlled trial in both clinical\nand primary care settings. Diabetes Care. 2000;23(10):1455-60.\n[20] Aubin HJ, Farley A, Lycett D, Lahmek P, Aveyard P. Weight\ngain in smokers after quitting cigarettes: Meta-analysis. BMJ.\n2012;345:e4439.\nCiter cet article\nDurlach V. Tabagisme et diab\u00e8te : le temps de l'action. Bull\nEpid\u00e9miol Hebd. 2022;(22): 392-8.\nfrance.fr/beh/2022/22/2022_22_2.html", "mimetype": "text/plain", "start_char_idx": 3950, "end_char_idx": 5703, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}}}